<SEC-DOCUMENT>0000950103-25-013761.txt : 20251029
<SEC-HEADER>0000950103-25-013761.hdr.sgml : 20251029
<ACCEPTANCE-DATETIME>20251028180800
ACCESSION NUMBER:		0000950103-25-013761
CONFORMED SUBMISSION TYPE:	424B8
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251029
DATE AS OF CHANGE:		20251028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251426154

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251426155

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B8
<SEQUENCE>1
<FILENAME>dp236412_424b8-us2522940d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 47%"><P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">October
    24, 2025</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Medium-Term
    Senior Notes, Series N</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Pricing
    Supplement No. 2025-USNCH29059</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed
    Pursuant to Rule 424(b)(8)</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration
    Statement Nos. 333-270327 and 333-270327-01</FONT></P></TD></TR>
  </TABLE>
<P STYLE="color: #59AE43; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Autocallable Contingent Coupon Equity Linked Securities
Linked to the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER Due July 29, 2030</P>

<P STYLE="color: #59AE43; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. The securities offer the potential for periodic contingent coupon payments at an annualized rate that, if
all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same maturity.
In exchange for this higher potential yield, you must be willing to accept the risks that (i) your actual yield may be lower than the
yield on our conventional debt securities of the same maturity because you may not receive one or more, or any, contingent coupon payments,
(ii) the value of what you receive at maturity may be significantly less than the stated principal amount of your securities, and may
be zero, and (iii) the securities may be automatically called for redemption prior to maturity beginning on the first potential autocall
date specified below. Each of these risks will depend on the performance of the underlying specified below. Although you will have downside
exposure to the underlying, you will not receive dividends with respect to the underlying or participate in any appreciation of the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD><B>The underlying tracks exposure to the S&amp;P 500 Futures Excess Return Index on a volatility-targeted, trend-adjusted basis, <I>less</I>
certain notional costs and <I>less</I> a decrement of 6% per annum. The underlying is highly risky because it may reflect highly leveraged
exposure to any decline in the S&amp;P 500 Futures Excess Return Index.&nbsp;&nbsp;The S&amp;P 500 Futures Excess Return Index tracks
futures contracts on the S&amp;P 500<SUP>&reg;</SUP> Index and is likely to underperform the S&amp;P 500<SUP>&reg;</SUP> Index because
of an implicit financing cost.&nbsp;&nbsp;In addition, notional costs and a decrement of 6% per annum will be a significant drag on the
underlying&rsquo;s performance.&nbsp;&nbsp;You should carefully review the section &ldquo;Summary Risk Factors&mdash;Risks relating to
the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER&rdquo; in this pricing supplement.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">&squarf;</TD><TD>Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of
not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 24, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 29, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation dates:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">November 24, 2025, December 24, 2025, January 26, 2026, February 24, 2026, March 24, 2026, April 24, 2026, May 26, 2026, June 24, 2026, July 24, 2026, August 24, 2026, September 24, 2026, October 26, 2026, November 24, 2026, December 24, 2026, January 25, 2027, February 24, 2027, March 24, 2027, April 26, 2027, May 24, 2027, June 24, 2027, July 26, 2027, August 24, 2027, September 24, 2027, October 25, 2027, November 24, 2027, December 27, 2027, January 24, 2028, February 24, 2028, March 24, 2028, April 24, 2028, May 24, 2028, June 26, 2028, July 24, 2028, August 24, 2028, September 25, 2028, October 24, 2028, November 24, 2028, December 26, 2028, January 24, 2029, February 26, 2029, March 26, 2029, April 24, 2029, May 24, 2029, June 25, 2029, July 24, 2029, August 24, 2029, September 24, 2029, October 24, 2029, November 26, 2029, December 24, 2029, January 24, 2030, February 25, 2030, March 25, 2030, April 24, 2030, May 24, 2030, June 24, 2030 and July 24, 2030 (the &ldquo;final valuation date&rdquo;), each subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Unless earlier redeemed, July 29, 2030</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon payment dates:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The third business day after each valuation date, except that the contingent coupon payment date following the final valuation date will be the maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to 1.1292% of the stated principal amount of the securities (equivalent to a contingent coupon rate of approximately 13.55% per annum) <B>if and only if</B> the closing value of the underlying on the immediately preceding valuation date is greater than or equal to the coupon barrier value. <B>If the closing value of the underlying on any valuation date is less than the coupon barrier value, you will not receive any contingent coupon payment on the immediately following contingent coupon payment date. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
you will receive at maturity for each security you then hold (in addition to the final contingent coupon payment, if applicable):&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.65pt; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.5in; text-indent: 0in">If
the final underlying value is <B>greater than or equal to</B> the final barrier value:&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.5in">$1,000&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.65pt; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&sect;&#9;</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: -11pt 0pt 0pt 0.5in; text-indent: 0in">If
the final underlying value is <B>less than</B> the final barrier value:&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0.5in">$1,000 + ($1,000 &times; the underlying return)&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
    and the final underlying value is less than the final barrier value, you will receive significantly less than the stated principal amount
    of your securities, and possibly nothing, at maturity, and you will not receive any contingent coupon payment at maturity.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">10,060.15, the closing value of the underlying on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the final valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon barrier value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">5,030.075, 50.00% of the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">5,030.075, 50.00% of the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 23%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 23%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 28%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(3)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$12.50</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$987.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,395,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$17,437.50</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,377,562.50</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) On the date of this pricing supplement, the estimated value of the
securities is $928.20 per security, which is less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s
proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time
after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) The issue price for investors purchasing the securities in fee-based
advisory accounts will be $987.50 per security, assuming no custodial fee is charged by a selected dealer, and up to $992.50 per security,
assuming the maximum custodial fee is charged by a selected dealer. See &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing
supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(3) For more information on the distribution of the securities, see
&ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee, CGMI and its affiliates
may profit from hedging activity related to this offering, even if the value of the securities declines. See &ldquo;Use of Proceeds and
Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 11pt"><B>Investing in the securities involves
risks not associated with an investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-7.</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, index supplement, prospectus supplement and prospectus are truthful or complete. Any
representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, index supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks
below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: rgb(89,174,67)"><B>Product Supplement No. EA-04-10 dated March 7, 2023</B></FONT></A></TD>
    <TD STYLE="width: 50%; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000095010325012421/dp235025_424b2-1701.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Index Supplement No. IS-17-01 dated September 29, 2025</B></FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE43"><B><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67); text-decoration: underline">Prospectus Supplement and Prospectus each dated March 7, 2023</A></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #59AE43"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Automatic early redemption:</B></FONT></TD>
    <TD STYLE="width: 77%"><FONT STYLE="font-size: 10pt">If, on any potential autocall date, the closing value of the underlying is greater than or equal to the initial underlying value, each security you then hold will be automatically called on that potential autocall date for redemption on the immediately following contingent coupon payment date for an amount in cash equal to $1,000.00 <I>plus</I> the related contingent coupon payment. <B>The automatic early redemption feature may significantly limit your potential return on the securities. If the underlying performs in a way that would otherwise be favorable, the securities are likely to be automatically called for redemption prior to maturity, cutting short your opportunity to receive contingent coupon payments. The securities may be automatically called for redemption as early as the first potential autocall date specified below.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Potential autocall dates:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The valuation dates scheduled to occur on October 26, 2026, November 24, 2026, December 24, 2026, January 25, 2027, February 24, 2027, March 24, 2027, April 26, 2027, May 24, 2027, June 24, 2027, July 26, 2027, August 24, 2027, September 24, 2027, October 25, 2027, November 24, 2027, December 27, 2027, January 24, 2028, February 24, 2028, March 24, 2028, April 24, 2028, May 24, 2028, June 26, 2028, July 24, 2028, August 24, 2028, September 25, 2028, October 24, 2028, November 24, 2028, December 26, 2028, January 24, 2029, February 26, 2029, March 26, 2029, April 24, 2029, May 24, 2029, June 25, 2029, July 24, 2029, August 24, 2029, September 24, 2029, October 24, 2029, November 26, 2029, December 24, 2029, January 24, 2030, February 25, 2030, March 25, 2030, April 24, 2030, May 24, 2030 and June 24, 2030</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">(i) The final underlying value <I>minus</I> the initial underlying value, <I>divided by</I> (ii) the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">17331BRL5 / US17331BRL52 </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the accompanying
product supplement contains important information about how the closing value of the underlying will be determined and about adjustments
that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events with respect
to the underlying. The accompanying index supplement contains information about the underlying that is not repeated in this pricing supplement.
It is important that you read the accompanying product supplement, index supplement, prospectus supplement and prospectus together with
this pricing supplement in connection with your investment in the securities. Certain terms used but not defined in this pricing supplement
are defined in the accompanying product supplement or the accompanying index supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Index Description</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">All information contained in this pricing supplement regarding the S&amp;P
500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER (the &ldquo;underlying&rdquo; or the &ldquo;Index&rdquo;) has
been derived from information provided by S&amp;P Dow Jones Indices LLC, the Index sponsor, without independent verification.&nbsp;&nbsp;This
information reflects the policies of, and is subject to change by, the Index sponsor.&nbsp;&nbsp;The Index sponsor has no obligation to
continue to publish the Index and may discontinue publication of the Index at any time. The Index launched on August 14, 2025 and, therefore,
has a limited performance history.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Index tracks exposure to the S&amp;P 500 Futures Excess Return Index
(which we refer to as the &ldquo;Underlying Futures Index&rdquo;) on a volatility-targeted, trend-adjusted basis, less certain notional
costs and less a decrement of 6% per annum.&nbsp;&nbsp;The Index has a volatility target of 40%, which it attempts to achieve by applying
leverage to its exposure to the Underlying Futures Index (up to a maximum of 500%) when the underlying volatility is less than the volatility
target, and by reducing its exposure to the Underlying Futures Index below 100% when the underlying volatility is greater than the volatility
target.&nbsp;&nbsp;The Index may reset its exposure to the Underlying Futures Index at each of four intraday windows during each index
business day based on a measure of the underlying volatility at the related intraday fixing time, subject to scaling up or down depending
on a measure of the intraday trend of the Underlying Futures Index at that time (and, for the fourth intraday window only, subject to
adjustment up or down based on the overnight mean-reversion trend), and may reset its exposure again at the closing of trading, all as
described in more detail in the accompanying Index Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Underlying Futures Index tracks the performance of a hypothetical
investment, rolled quarterly, in futures contracts on the S&amp;P 500<SUP>&reg;</SUP> Index, and accordingly is expected to reflect the
performance of the S&amp;P 500<SUP>&reg;</SUP> Index less an implicit financing cost.&nbsp;&nbsp;The S&amp;P 500<SUP>&reg;</SUP> Index
consists of the common stocks of 500 issuers selected to provide a performance benchmark for the large capitalization segment of the U.S.
equity market.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The methodology of the Index is premised on the following key assumptions:
(1) that there will be an inverse relationship between performance and volatility, so that the Underlying Futures Index will tend to increase
in times of lower volatility and decline in times of higher volatility; (2) that short-term intraday trends in the value of the Underlying
Futures Index will tend to continue; (3) that the Index rules can effectively identify when conditions are favorable for an overnight
mean-reversion in the Underlying Futures Index and effectively adjust its exposure to the Underlying Futures Index up or down in response;
(4) that the applicable measures of underlying volatility used by the Index will be effective predictors of future volatility of the Underlying
Futures Index from one intraday window to the next; and (5) that the volatility target for the Index will be an effective level of volatility
at which to draw the line between leveraged exposure and deleveraged exposure to the Underlying Futures Index.&nbsp;&nbsp;If these assumptions
prove to be consistently correct, then the Index has the potential to outperform the Underlying Futures Index by participating in increases
on a leveraged basis and declines on a deleveraged basis.&nbsp;&nbsp;There is no guarantee, however, that these assumptions will be proven
correct over any given time period.&nbsp;&nbsp;If any of these assumptions does not prove to be consistently correct, then the Index may
perform poorly as a result of having highly leveraged exposure to the Underlying Futures Index at a time of declines and/or having reduced
exposure to the Underlying Futures Index at a time of increases.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the Index is not consistently successful in increasing exposure to
the Underlying Futures Index in advance of increases in the Underlying Futures Index and reducing exposure to the Underlying Futures Index
in advance of declines, then the Index is also expected to be subject to a &ldquo;decay&rdquo; effect, which will exacerbate the decline
in the Index that results from having highly leveraged exposure to declines in the Underlying Futures Index.&nbsp;&nbsp;The decay effect
would result from the fact that the Index resets its exposure to the Underlying Futures Index multiple times each index business day,
and would manifest any time the Underlying Futures Index moves in one direction from one intraday window to the next and another direction
from that subsequent intraday window to the next after that.&nbsp;&nbsp;The decay effect would result because resetting exposure after
an increase but in advance of a decline would cause the Index to have increased exposure to that decline, and resetting exposure following
a decline but in advance of an increase would cause the Index to have decreased exposure to that increase.&nbsp;&nbsp;The more this fact
pattern repeats, the lower the performance of the Index would be relative to the performance of the Underlying Futures Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">It is important to understand that the Index provides exposure to the
S&amp;P 500<SUP>&reg;</SUP> Index that:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>may be leveraged up to 500%, or alternatively may reflect less than 100% participation;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>is reduced by an implicit financing cost;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>may be subject to a decay effect;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>is reduced by notional costs that will be greater with more frequent and larger adjustments of the exposure of the Index to the Underlying
Futures Index; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>is reduced by a decrement of 6% per annum.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As a result of these features, the Index may significantly underperform
the S&amp;P 500<SUP>&reg;</SUP> Index.&nbsp;&nbsp;The Index is likely to significantly underperform the S&amp;P 500<SUP>&reg;</SUP> Index
if it is not consistently successful in increasing exposure to the Underlying Futures Index in advance of increases in the Underlying
Futures Index and reducing exposure to the Underlying Futures Index in advance of declines in the Underlying Futures Index.&nbsp;&nbsp;The
Index may significantly underperform the S&amp;P 500<SUP>&reg;</SUP> Index even if it is consistently successful in these respects because
of the implicit financing cost, the notional costs and the decrement, or because the reduced exposure of the Index to the Underlying Futures
Index at a time of a decline may nevertheless reflect significantly greater than 100% participation in the decline of the Underlying Futures
Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Certain features of the Index &ndash; including the fact that it references
the Underlying Futures Index, and not the S&amp;P 500<SUP>&reg;</SUP> Index directly, the deduction of notional costs and the decrement
of 6% per annum &ndash; are designed to reduce and/or offset the cost to us and our affiliates of hedging transactions that we intend
to enter into in connection with the securities as compared to an otherwise comparable index without these features.&nbsp;&nbsp;These
features will reduce the performance of the Index as compared to an otherwise comparable index without these features.&nbsp;&nbsp;The
reduced and/or offset cost of hedging may make it possible for certain terms of the securities to be more favorable to you than would
otherwise be the case.&nbsp;&nbsp;However, there can be no assurance that these more favorable terms will offset the negative effects
of these features on the performance of the Index, and your return on the securities may ultimately be less favorable than it would have
been without these more favorable terms but with an index that does not contain these features.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This section contains only a summary description of the Index and does
not describe all of its important features in detail.&nbsp;&nbsp;Before investing in the securities, you should carefully review the more
detailed description of the Index in the accompanying Index Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples in the first section below illustrate how to determine
whether a contingent coupon will be paid and whether the securities will be automatically called for redemption following a valuation
date that is also a potential autocall date. The examples in the second section below illustrate how to determine the payment at maturity
on the securities, assuming the securities are not automatically redeemed prior to maturity. The examples are solely for illustrative
purposes, do not show all possible outcomes and are not a prediction of any payment that may be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying value, coupon barrier value or final barrier value. For the actual initial underlying value,
coupon barrier value and final barrier value, see the cover page of this pricing supplement. We have used these hypothetical values, rather
than the actual values, to simplify the calculations and aid understanding of how the securities work. However, you should understand
that the actual payments on the securities will be calculated based on the actual initial underlying value, coupon barrier value and final
barrier value, and not the hypothetical values indicated below. For ease of analysis, figures below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="width: 30%; border: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical initial underlying value:</B></FONT></TD>
    <TD STYLE="width: 70%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt">100.00</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical coupon barrier value:</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt">50.00 (50.00% of the hypothetical initial underlying value)</FONT></TD></TR>
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Hypothetical final barrier value:</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid"><FONT STYLE="font-size: 10pt">50.00 (50.00% of the hypothetical initial underlying value)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of Contingent Coupon Payments
and any Payment upon Automatic Early Redemption Following a Valuation Date that is also a Potential Autocall Date</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The three hypothetical examples below illustrate how to determine whether
a contingent coupon will be paid and whether the securities will be automatically redeemed following a hypothetical valuation date that
is also a potential autocall date, assuming that the closing value of the underlying on the hypothetical valuation date is as indicated
below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical closing value of the underlying on hypothetical valuation date</B></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment per $1,000.00 security on related contingent coupon payment date</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 1</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">85<BR>
(greater than coupon barrier value; less than initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$11.292</B><BR>
(contingent coupon is paid; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 2</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">40<BR>
(less than coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupon; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 3</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">110<BR>
(greater than coupon barrier value and initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,011.292</B><BR>
(contingent coupon is paid; securities redeemed)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 1:</B></FONT> On the hypothetical
valuation date, the closing value of the underlying is greater than the coupon barrier value but less than the initial underlying value.
As a result, investors in the securities would receive the contingent coupon payment on the related contingent coupon payment date and
the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 2:</B></FONT> On the hypothetical
valuation date, the closing value of the underlying is less than the coupon barrier value. As a result, investors would not receive any
payment on the related contingent coupon payment date and the securities would not be automatically redeemed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive a contingent coupon
on the contingent coupon payment date following a valuation date if the closing value of the underlying on that valuation date is less
than the coupon barrier value.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 3:</B></FONT> On the hypothetical
valuation date, the closing value of the underlying is greater than both the coupon barrier value and the initial underlying value. As
a result, the securities would be automatically redeemed on the related contingent coupon payment date for an amount in cash equal to
$1,000.00 <I>plus</I> the related contingent coupon payment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the hypothetical valuation date were not also a potential autocall
date, the securities would not be automatically redeemed on the related contingent coupon payment date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of the Payment at Maturity
on the Securities</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The next three hypothetical examples illustrate the calculation of the
payment at maturity on the securities, assuming that the securities have not been earlier automatically redeemed and that the final underlying
value is as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value</B></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment at maturity per $1,000.00 security</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 4</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">110<BR>
(greater than final barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,011.292</B><BR>
(contingent coupon is paid)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 5</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">30<BR>
(less than final barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$300.00</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 6</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">20<BR>
(less than final barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$200.00</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 4:</B></FONT> The final underlying
value is greater than the final barrier value. Accordingly, at maturity, you would receive the stated principal amount of the securities
<I>plus</I> the contingent coupon payment due at maturity, but you would not participate in the appreciation of the underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 5:</B></FONT> The final underlying
value is less than the final barrier value. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000.00 + ($1,000.00 &times; the underlying
return)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + ($1,000.00 &times; -70.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + -$700.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $300.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value is less than the
final barrier value, you would lose a significant portion of your investment in the securities. In addition, because the final underlying
value is below the coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 6:</B></FONT> The final underlying
value is less than the final barrier value. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000.00 + ($1,000.00 &times; the underlying
return)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + ($1,000.00 &times; -80.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000.00 + -$800.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $200.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value is less than the
final barrier value, you would lose a significant portion of your investment in the securities. In addition, because the final underlying
value is below the coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is possible that the closing value of the underlying will be less
than the coupon barrier value on each valuation date and less than the final barrier value on the final valuation date, such that you
will not receive any contingent coupon payments over the term of the securities and will receive significantly less than the stated principal
amount of your securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with the underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Risks relating to the securities</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed prior
to maturity, your payment at maturity will depend on the final underlying value. If the final underlying value is less than the final
barrier value, you will lose 1% of the stated principal amount of your securities for every 1% by which the underlying has declined from
the initial underlying value. There is no minimum payment at maturity on the securities, and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive any contingent coupon on the contingent coupon payment date following any valuation date on which the closing
value of the underlying is less than the coupon barrier value.</B> A contingent coupon payment will be made on a contingent coupon payment
date if and only if the closing value of the underlying on the immediately preceding valuation date is greater than or equal to the coupon
barrier value. If the closing value of the underlying on any valuation date is less than the coupon barrier value, you will not receive
any contingent coupon payment on the immediately following contingent coupon payment date. If the closing value of the underlying on each
valuation date is below the coupon barrier value, you will not receive any contingent coupon payments over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk.</B> The securities offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities, including
the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates and the risk that
the value of what you receive at maturity may be significantly less than the stated principal amount of your securities and may be zero.
The volatility of the closing value of the underlying is an important factor affecting these risks. Greater expected volatility of the
closing value of the underlying as of the pricing date may result in a higher contingent coupon rate, but would also represent a greater
expected likelihood as of the pricing date that the closing value of the underlying on one or more valuation dates will be less than the
coupon barrier value, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities
and that the final underlying value will be less than the final barrier value, such that you will not be repaid the stated principal amount
of your securities at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the underlying.</B> The potential contingent coupon payments
on the securities are the compensation you receive for assuming the downside risk of the underlying, as well as all the other risks of
the securities. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than you currently anticipate. First,
the actual yield you realize on the securities could be lower than you anticipate because the coupon is &ldquo;contingent&rdquo; and you
may not receive a contingent coupon payment on one or more, or any, of the contingent coupon payment dates. Second, the contingent coupon
payments are the compensation you receive not only for the downside risk of the underlying, but also for all of the other risks of the
securities, including the risk that the securities may be automatically redeemed prior to maturity, interest rate risk and our and Citigroup
Inc.&rsquo;s credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon
payments may turn out to be inadequate to compensate you for all the risks of the securities, including the downside risk of the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive contingent coupon payments.</B>
On any potential autocall date, the securities will be automatically called for redemption if the closing value of the underlying on that
potential autocall date is greater than or equal to the initial underlying value. As a result, if the underlying performs in a way that
would otherwise be favorable, the securities are likely to be automatically redeemed, cutting short your opportunity to receive contingent
coupon payments. If the securities are automatically redeemed prior to maturity, you may not be able to reinvest your funds in another
investment that provides a similar yield with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the underlying, but no upside exposure to the underlying.</B> You will not participate
in any appreciation in the value of the underlying over the term of the securities. Consequently, your return on the securities will be
limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on the underlying over the
term of the securities. In addition, as an investor in the securities, you will not receive any dividends or other distributions or have
any other rights with respect to the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing value of the underlying solely on the valuation dates, which makes
the securities particularly sensitive to volatility in the closing value of the underlying on or near the valuation dates.</B> Whether
the contingent coupon will be paid on any given contingent coupon payment date and whether the securities will be automatically redeemed
prior to maturity will depend on the closing value of the underlying solely on the applicable valuation dates, regardless of the closing
value of the underlying on other days during the term of the securities. If the securities are not automatically redeemed prior to maturity,
what you receive at maturity will depend solely on the closing value of the underlying on the final valuation date, and not on any other
day during the term of the securities. Because the performance of the securities depends on the closing value of the underlying on a limited
number of dates, the</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">securities will be particularly sensitive
to volatility in the closing value of the underlying on or near the valuation dates. You should understand that the closing value of the
underlying has historically been highly volatile.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of the closing value of the underlying, the dividend
yield on the underlying and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an
underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may prove to
be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities set
forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying,
the dividend yield on the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s creditworthiness,
as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating to the Securities&mdash;Risk
Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based on many unpredictable factors&rdquo;
in the accompanying product supplement. Changes in the closing value of the underlying may not result in a comparable change in the value
of your securities. You should understand that the value of your securities at any time prior to maturity may be significantly less than
the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of the underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlying is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlying or in instruments
related to the underlying, and may publish research or express opinions, that in each case are inconsistent with an investment linked
to the underlying. These and other activities of our affiliates may affect the closing value of the underlying in a way that negatively
affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of the underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the underlying
or in financial instruments related to the underlying and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlying or in financial instruments related to the underlying on a regular basis (taking long or short positions
or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers. These activities
could affect the closing value of the underlying in a way that negatively affects the value of and your return on the securities. They
could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlying
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to the underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
<FONT STYLE="background-color: white">supplement</FONT>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If a material modification event occurs during the term of the securities, we may redeem the securities early for an amount that
may result in a significant loss on your investment. </B>See &ldquo;Additional Terms of the Securities&mdash;Material Modification of
the S&amp;P 500 Dynamic Participation Index&rdquo; in this pricing supplement for information about the events that may constitute a material
modification event. If a material modification event occurs, we may redeem the securities prior to the maturity date for an amount equal
to the early redemption amount determined as of the early redemption notice date. The early redemption amount will be determined in a
manner based upon (but not necessarily identical to) CGMI&rsquo;s then contemporaneous practices for determining secondary market bid
prices for the securities and similar instruments, subject to the exceptions and more detailed provisions set forth under &ldquo;Additional
Terms of the Securities&mdash;Material Modification of the S&amp;P 500 Dynamic Participation Index&rdquo; below. As discussed above, any
secondary market bid price is likely to be less than the issue price and, absent favorable changes in market conditions and other relevant
factors, is also likely to be less than the estimated value of the securities set forth on the cover page of this pricing supplement.
Accordingly, if a material modification event occurs, there is a significant likelihood that the early redemption amount you receive will
result in a loss on your investment in the securities. The early redemption amount may be significantly less than the amount you would
have received had we not elected to redeem the securities and had you been able instead to hold them to maturity. You may lose up to all
of <FONT STYLE="background-color: white">your</FONT> investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent may make determinations in connection with a material modification event and the early redemption amount
that could adversely affect your return upon early redemption. </B>The calculation agent will be required to determine whether a material
modification event has occurred. If the calculation agent determines that a material modification event has occurred and as a result we
elect to redeem the securities upon the occurrence of a material modification event, you may incur a significant loss on your investment
in the securities. In addition, the calculation agent has broad discretion to determine the early redemption amount, including the ability
to make adjustments to proprietary pricing models and inputs to those models in good faith and in a commercially reasonable manner. The
fact that the calculation agent is our affiliate may cause it to have interests that are adverse to yours as a holder of the securities.
Under the terms of the securities, the calculation agent has the authority to make determinations that may protect our economic interests
while resulting in a significant loss to you on your <FONT STYLE="background-color: white">investment</FONT> in the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.&nbsp;&nbsp;</B>There is no direct legal authority
regarding the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service
(the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS
or a court might not agree with the treatment of the securities as described in &ldquo;United States Federal Tax Considerations&rdquo;
below.&nbsp;&nbsp;If the IRS were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership
and disposition of the securities might be materially and adversely affected.&nbsp;&nbsp;Moreover, future legislation, Treasury regulations
or IRS guidance could adversely affect the U.S. federal tax treatment of the <FONT STYLE="background-color: white">securities</FONT>,
possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">Non-U.S. investors
should note that persons having withholding responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S.
investor, generally at a rate of 30%.&nbsp;&nbsp;To the extent that we have withholding responsibility in respect of the securities, we
intend to so withhold. </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"><FONT STYLE="background-color: white">You
should read carefully the discussion under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to
the Securities&rdquo; in the accompanying product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing
supplement.&nbsp;&nbsp;You should also consult your tax adviser regarding the U.S. federal tax consequences of an investment in the securities,
as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Risks relating to the S&amp;P
500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>The following is a description
of risks relating to the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER, which we refer to in this section
as the &ldquo;Index&rdquo;. The following discussion of risks should be read together with the section &ldquo;Description of the S&amp;P
500 Futures Intraday Edge Volatility Indices&rdquo; in the accompanying index supplement, which defines and further describes a number
of the terms and concepts referred to below.</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index is highly risky because it may reflect highly leveraged exposure to the Underlying
Futures Index and may therefore experience a decline that is many multiples of any decline in the Underlying Futures Index.</B>&nbsp;&nbsp;The
Index tracks exposure to the S&amp;P 500 Futures Excess Return Index (which we refer to as the &ldquo;Underlying Futures Index&rdquo;)
on a volatility-targeted, trend-adjusted basis, <I>less</I> certain notional costs and <I>less</I> a decrement of 6% per annum.&nbsp;&nbsp;The
Index has a volatility target of 40%, which it attempts to achieve by applying leverage to its exposure to the Underlying Futures Index
(up to a maximum of 500%) when the underlying volatility is less than the volatility target, and by reducing its exposure to the Underlying
Futures Index below 100% when the underlying volatility is greater than the volatility target.&nbsp;&nbsp;It is expected that the underlying
volatility will frequently be less than the volatility target, and therefore it is expected that the Index will frequently have leveraged
(more than 100%) exposure to the Underlying Futures Index.&nbsp;&nbsp;If the Underlying Futures Index declines at a time when the Index
has leveraged exposure to it, the decline in the Index will be equal to the decline in the Underlying Futures Index <I>multiplied by</I>
the leveraged exposure (subject to further reduction as a result of the notional costs and the decrement). For example, if the Underlying
Futures Index declines by 5% at a time when the Index has 500% leveraged exposure to the Underlying Futures Index, the Index will decline
by 25% over that time (subject to further reduction as a result of the notional costs and the decrement).&nbsp;&nbsp;This potential for
losses on a highly leveraged basis makes the Index highly risky.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index may realize significant losses if it is not consistently successful in increasing
exposure to the Underlying Futures Index in advance of increases in the Underlying Futures Index and reducing exposure to the Underlying
Futures Index in advance of declines.</B>&nbsp;&nbsp;The Index methodology is premised on the following key assumptions: (1) that there
will be an inverse relationship between performance and volatility, so that the Underlying Futures Index will tend to increase in times
of lower volatility and decline in times of higher volatility; (2) that short-term intraday trends in the value of the Underlying Futures
Index will tend to continue; (3) that the Index rules can effectively identify when conditions are favorable for an overnight mean-reversion
in the Underlying Futures Index and effectively adjust its exposure to the Underlying Futures Index up or down in response; (4) that the
measures of underlying volatility used by the Index will be effective predictors of future volatility of the Underlying Futures Index
from one intraday window to the next; and (5) that 40% will be an effective level of volatility at which to draw the line between leveraged
exposure and deleveraged exposure to the Underlying Futures Index.&nbsp;&nbsp;There is no guarantee that these assumptions will be proven
correct over any given time period.&nbsp;&nbsp;If any of these assumptions does not prove to be consistently correct, then the Index may
perform poorly as a result of having highly leveraged exposure to the Underlying Futures Index at a time of declines and/or having reduced
exposure to the Underlying Futures Index at a time of increases.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>A significant portion of the Index may be hypothetically uninvested, dampening returns.</B>&nbsp;&nbsp;If
at any time the realized volatility of the Interim Index over the preceding 40 index business days exceeds the Index&rsquo;s volatility
target, the Index will have less than 100% exposure to the Interim Index, and the difference will be hypothetically uninvested.&nbsp;&nbsp;As
a result, even at a time when the Interim Index reflects significantly more than 100% exposure to the Underlying Futures Index, the Index
may reflect significantly less than 100% exposure to the Interim Index, lessening the impact on the Index of the leveraged exposure of
the Interim Index to the Underlying Futures Index.&nbsp;&nbsp;Moreover, at any time when the underlying volatility is greater than the
volatility target, the volatility-targeted exposure of the Interim Index to the Underlying Futures Index will be less than 100%.&nbsp;&nbsp;Even
at a time when the volatility-targeted exposure of the Interim Index to the Underlying Futures Index would be greater than 100%, the actual
exposure of the Interim Index to the Underlying Futures Index may be reduced below 100% by the intraday trend and/or overnight mean-reversion
trend adjustments.&nbsp;&nbsp;Taken together, these mechanisms may result in the Index participating in less than 100% of the performance
of the Underlying Futures Index, with the difference deemed to be hypothetically uninvested.&nbsp;&nbsp;No interest or other return will
accrue on any portion of the Index (including the Interim Index) that is hypothetically uninvested, which will dampen Index returns, but
the decrement will be deducted in an amount calculated on the full Index value.&nbsp;&nbsp;If at any time the Index has less than 100%
effective exposure to the Underlying Futures Index, the Index will not fully participate in any appreciation of the Underlying Futures
Index.&nbsp;&nbsp;For example, if the Index has 50% exposure to the Underlying Futures Index at a time when the Underlying Futures Index
appreciates by 5%, the Index would appreciate by only 2.5% (before giving effect to the notional costs and the decrement).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index may significantly underperform the S&amp;P 500<SUP>&reg;</SUP> Index.</B>&nbsp;&nbsp;It
is important to understand that the Index provides exposure to the S&amp;P 500<SUP>&reg;</SUP> Index that: (1) may be leveraged up to
500%, or alternatively may reflect less than 100% participation; (2) is reduced by an implicit financing cost; (3) may be subject to a
decay effect; (4) is reduced by notional costs; and (5) is reduced by a decrement of 6% per annum.&nbsp;&nbsp;As a result of these features,
the Index may significantly underperform the S&amp;P 500<SUP>&reg;</SUP> Index.&nbsp;&nbsp;The Index is likely to significantly underperform
the S&amp;P 500<SUP>&reg;</SUP> Index if it is not consistently successful in increasing exposure to the Underlying Futures Index in advance
of increases in the Underlying Futures Index and reducing exposure to the Underlying Futures Index in advance of declines in the Underlying
Futures Index.&nbsp;&nbsp;The Index may significantly underperform the S&amp;P 500<SUP>&reg;</SUP> Index even if it is consistently successful
in these respects because of the implicit financing cost, the notional costs and the decrement, or because the reduced exposure the Index
has to the Underlying Futures Index at a time of a decline may nevertheless reflect significantly greater than 100% participation in the
decline of the Underlying Futures Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index may experience significantly greater volatility than its volatility target.</B>&nbsp;&nbsp;The
Index seeks to implement its volatility target in two steps.&nbsp;&nbsp;First, the Interim Index determines a volatility-targeted exposure
to the Underlying Futures Index for each intraday window in a manner that seeks to align the volatility of the Interim Index with the
volatility target.&nbsp;&nbsp;Second, the Index adjusts its exposure to the Interim Index daily pursuant to an end-of-day volatility target
adjustment.&nbsp;&nbsp;Despite these steps, the Index may experience significantly greater volatility than its volatility target for a
number of reasons.&nbsp;&nbsp;The Interim Index determines its exposure to the Underlying Futures Index based not only on the volatility-targeted
exposure, but also on intraday trend and overnight mean-reversion trend inputs.&nbsp;&nbsp;Those inputs may result in the exposure of
the Interim Index to the Underlying Futures Index being increased to a level that is significantly higher than the volatility-targeted
exposure, and the Interim Index may experience significantly more volatility than the volatility target as a result.&nbsp;&nbsp;Moreover,
although the end-of-day volatility target adjustment is intended to reduce the exposure of the Index to the Interim Index to counteract
this, the end-of-day volatility </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">target adjustment is
based on the realized volatility of the Interim Index over a look-back period of 40 index business days.&nbsp;&nbsp;If there is a significant
increase in the volatility of the Interim Index, it may be a significant period of time before that increased volatility is meaningfully
reflected in the 40-day lookback period.&nbsp;&nbsp;If the Index experiences significantly great volatility than its volatility target,
it may be riskier than expected and may experience a significantly greater decline than it would have if it had maintained its volatility
target.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index&rsquo;s intraday trend-following mechanism may not be effective.</B>&nbsp;&nbsp;The
Index incorporates a trend-following mechanism, in which it will scale the volatility-targeted exposure of the Interim Index to the Underlying
Futures Index up or down depending on a measure of the intraday trend of the Underlying Futures Index.&nbsp;&nbsp;Trend-following methodologies
such as the one followed by the Index are premised on the notion that equity markets exhibit momentum, whereby recent performance is predictive
of future performance.&nbsp;&nbsp;Trend-following methodologies perform poorly, however, when this turns out not to be the case.&nbsp;&nbsp;There
can be no guarantee that recent performance will be predictive of future performance.&nbsp;&nbsp;Trend-following methodologies perform
particularly poorly in choppy markets, where they can be subject to whipsaws &ndash; increasing exposure following a recent increase and
just in time to participate on a higher-exposure basis in a decline that follows the increase, at which point they decrease exposure following
the decline and just when the underlying market begins to increase again.&nbsp;&nbsp;Moreover, even if the Underlying Futures Index does
exhibit trend-following behavior, there can be no assurance that the particular methodology followed by the Index will effectively identify
the trend or capitalize on it.&nbsp;&nbsp;If the Underlying Futures Index does not exhibit momentum, or if the Index&rsquo;s intraday
trend-following methodology is not effective in identifying trends and capitalizing on them, the Index&rsquo;s trend-following mechanism
may result in scaling up the exposure to the Underlying Futures Index ahead of declines, and scaling down exposure ahead of increases,
which would result in poor performance.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index&rsquo;s overnight mean-reversion mechanism may not be effective.</B>&nbsp;&nbsp;The
Index incorporates an overnight mean-reversion mechanism, in which it will adjust the trend-adjusted, volatility-targeted exposure to
the Underlying Futures Index upward at the fourth intraday window at any time when it determines that conditions are favorable for a positive
overnight mean-reversion, and will adjust that exposure downward at any time when it determines that conditions are favorable for a negative
overnight mean-reversion.&nbsp;&nbsp;The Index&rsquo;s overnight mean-reversion mechanism is premised on the assumption that equity markets
may at times exhibit a tendency to revert to a longer term mean (on an overnight basis) after a short-term dip, and the Index seeks to
capitalize on that tendency by identifying a time when a short-term dip has occurred and when the equity markets are due for a positive
mean-reversion and increasing exposure to the Underlying Futures Index accordingly at the fourth intraday window.&nbsp;&nbsp;There can
be no assurance, however, that the Underlying Futures Index will exhibit mean-reversion behavior when the Index expects it to do so, or
at all.&nbsp;&nbsp;Even if the Underlying Futures Index does exhibit mean-reversion behavior, the particular methodology of the Index
may fail to accurately identify when it will do so or may fail to capitalize on that.&nbsp;&nbsp;If the Underlying Futures Index does
not exhibit mean-reversion behavior when the Index expects it to do so, the Index may increase its exposure to the Underlying Futures
Index in a falling market that may continue to fall long after the Index has increased exposure, worsening Index returns as a result.&nbsp;&nbsp;Conversely,
if the Underlying Futures Index does exhibit mean-reversion behavior when the Index does not expect it to, the Index will have reduced
its exposure to the Underlying Futures Index at a time when the Underlying Futures Index has rebounded from the short-term dip, which
will cause Index performance to be less favorable than it would have been if it had not tried to time the mean-reversion.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index may perform poorly in temporary market downturns.</B>&nbsp;&nbsp;There is a time
lag inherent in the Index&rsquo;s volatility targeting mechanisms.&nbsp;&nbsp;Unless the VIX signal is 1, the Interim Index will determine
its volatility-targeted exposure to the Underlying Futures Index based on a backward-looking measure of realized volatility of the Underlying
Futures Index.&nbsp;&nbsp;Similarly, the Index will apply its end-of-day volatility target adjustment to its exposure to the Interim Index
based on a backward-looking measure of realized volatility of the Interim Index.&nbsp;&nbsp;If there is a sudden spike in volatility and
a corresponding sharp decline in the Underlying Futures Index, the Index may have a relatively high degree of exposure to the Underlying
Futures Index at the time of the decline and may therefore have a high degree of exposure to that decline.&nbsp;&nbsp;The Index may subsequently
reduce its exposure to the Underlying Futures Index once the increased volatility has been sufficiently reflected in the Index&rsquo;s
realized volatility measures, but by then the Underlying Futures Index may have already stopped its decline and started to recover.&nbsp;&nbsp;Given
the time lag, the Index may not increase its exposure to the Underlying Futures Index until well after the recovery has already taken
place.&nbsp;&nbsp;Taken together, these factors may cause the Index to perform particularly poorly in a temporary market downturn &ndash;
a sudden significant decline that is quickly reversed.&nbsp;&nbsp;In that scenario, the Index would participate on a highly leveraged
basis in the decline and then fail to participate fully in the recovery.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index may be adversely affected by a &ldquo;decay&rdquo; effect.</B>&nbsp;&nbsp;If the
Index is not consistently successful in increasing exposure to the Underlying Futures Index in advance of increases in the Underlying
Futures Index and reducing exposure to the Underlying Futures Index in advance of declines in the Underlying Futures Index, then the Index
is also expected to be subject to a &ldquo;decay&rdquo; effect, which will exacerbate the decline that results from having highly leveraged
exposure to declines in the Underlying Futures Index.&nbsp;&nbsp;The decay effect would result from the fact that the Index resets its
exposure to the Underlying Futures Index multiple times each index business day, and would manifest any time the Underlying Futures Index
moves in one direction from one intraday window to the next and another direction from that subsequent intraday window to the next after
that.&nbsp;&nbsp;The decay effect would result because resetting exposure after an increase but in advance of a decline would cause the
Index to have increased exposure to that decline, and resetting exposure following a decline but in advance of an increase would cause
the Index to have decreased exposure to that increase.&nbsp;&nbsp;The more this fact pattern repeats, the lower the performance of the
Index would be relative to the performance of the Underlying Futures Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Underlying Futures Index is expected to underperform the S&amp;P 500<SUP>&reg;</SUP>
Index because of an implicit financing cost.</B>&nbsp;&nbsp;The Underlying Futures Index is a futures-based index.&nbsp;&nbsp;As a futures-based
index, it is expected to reflect not only the performance of its reference index (the S&amp;P 500<SUP>&reg;</SUP> Index), but also the
implicit cost of a financed position in that reference index.&nbsp;&nbsp;The cost of this financed position will adversely affect the
value of the Underlying Futures Index.&nbsp;&nbsp;Any increase in market interest rates will be expected to further increase this implicit
financing cost and will increase the negative effect on the performance of the Underlying Futures Index.&nbsp;&nbsp;Because of this implicit
financing cost, the Underlying Futures Index is expected to underperform the total return performance of the S&amp;P 500<SUP>&reg;</SUP>
Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The performance of the Index will be reduced by notional costs and by a decrement of 6% per
annum.</B> Two types of notional costs are deducted from the performance of the Index.&nbsp;&nbsp;Notional transaction costs are deducted
each time there is a change in the exposure of the Interim Index to the Underlying Futures Index or in the exposure of the Index to the
Interim Index.&nbsp;&nbsp;Changes in the exposure may occur as </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">often as five times
a day &ndash; during each of the four intraday windows, and again pursuant to the end-of-day volatility target adjustment.&nbsp;&nbsp;The
more frequent the changes in exposure and the larger the changes are in size, the greater the amount of the notional transaction costs.&nbsp;&nbsp;In
addition to the notional transaction costs, notional replication costs are deducted on a daily basis from the level of the Interim Index.&nbsp;&nbsp;The
greater the exposure of the Interim Index to the Underlying Futures Index, the greater the size of the notional replication costs. Moreover,
the performance of the Index will be reduced by a decrement of 6% per annum, which will be calculated on the full value of the Index,
including any portion that is hypothetically uninvested.&nbsp;&nbsp;The notional costs and the decrement will be a significant drag on
the performance of the Index, potentially offsetting positive returns that would otherwise result from the Index methodology, exacerbating
negative returns of the Index methodology and causing the level of the Index to decline steadily if the return of the Index methodology
would otherwise be relatively flat.&nbsp;&nbsp;The Index will not appreciate unless the return of the Index methodology is sufficient
to offset the negative effects of the notional costs and the decrement, and then only to the extent that the return of the Index methodology
is greater than the notional costs and the decrement. As a result of the notional costs and the decrement, the level of the Index may
decline even if the return of the Index methodology would otherwise have been positive.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The decrement of 6% per annum may reduce the annual return of the Index by more (and possibly significantly more) than 6%.&nbsp;&nbsp;</B>The
decrement is deducted from the level of the Index on each index business day at a rate of 6% per annum.&nbsp;&nbsp;Higher levels of the
Index over any given period will therefore result in larger deductions.&nbsp;&nbsp;Moreover, while the decrement will reduce the <U>level</U>
of the Index at a rate equal to 6% per annum, the effect of the decrement on the <U>return</U> of the Index over an annual period is likely
to be greater, and may be significantly greater, than 6% if the level of the Index has appreciated over that annual period.&nbsp;&nbsp;For
example, if the level of the Index <U>before</U> giving effect to the decrement were to increase from 100 to 150 over an annual period,
the level of the Index <U>after</U> giving effect to the decrement might be 141, which is 6% less than 150.&nbsp;&nbsp;In this scenario,
the return of the Index <U>before</U> giving effect to the decrement would have been 50%, while the return of the Index <U>after</U> giving
effect to the decrement would have been 41% -- resulting in a return of the Index over this annual period that is 9% lower than it would
have been before giving effect to the decrement.&nbsp;&nbsp;This example is not intended to be a prediction of the performance of the
Index over any given period &ndash; it is solely intended to illustrate how the impact of the decrement on the return of the Index may
be significantly greater than 6% per annum.&nbsp;&nbsp;These effects will be even greater over periods longer than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The negative impact of notional costs on the annual return of the Index may be greater than the absolute amount by which notional
costs reduce the level of the Index.</B>&nbsp;&nbsp;Notional costs will negatively affect the annual return of the Index in the same way
that the decrement does, as described in the preceding risk factor.&nbsp;&nbsp;Notional costs are deducted from the level of the Index
or the Interim Index and, as a result, higher levels of the Index or the Interim Index will result in larger deductions.&nbsp;&nbsp;Moreover,
as with the decrement and in the same manner described in the preceding risk factor, if the Index or the Interim Index appreciates over
any annual period, notional costs will negatively impact the annual return of the Index over that period by more than the percentage that
is deducted from the level of the Index or the Interim Index.&nbsp;&nbsp;The hypothetical back-tested and historical information regarding
the impact of notional costs on the performance of the Index that is included in this pricing supplement reflects the impact of notional
costs on the level of the Index &ndash; if these costs were expressed in terms of the impact on the annual return over any period over
which the Index has appreciated, they would be greater.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The manner in which the Index measures underlying volatility may not be effective.</B>&nbsp;&nbsp;The
Index will measure the underlying volatility on a given index business day based on implied volatility if the VIX signal on the preceding
index business day was 1, and based on realized volatility if the VIX signal on the preceding index business day was 0.&nbsp;&nbsp;The
VIX signal will be 1 when the level of the Cboe Volatility Index (the &ldquo;VIX&rdquo;) has exceeded its 200-day moving average for more
than 6 consecutive index business days, and will be 0 when the level of the VIX has been less than or equal to its 200-day moving average
for more than 3 consecutive index business days (and otherwise will be the same as on the preceding index business day).&nbsp;&nbsp;The
VIX is a measure of implied volatility of large-cap U.S. stocks over the next 30 days, calculated based on the prices of certain put and
call options on the S&amp;P 500<SUP>&reg;</SUP> Index.&nbsp;&nbsp;As a result, the Index is designed to use the forward-looking implied
volatility measurement at a time when implied volatility (as reflected in the VIX) is relatively elevated, and to use the backward-looking
realized volatility measurement at a time of relatively lower implied volatility.&nbsp;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>This approach to determining the underlying volatility is premised on the notion that forward-looking
implied volatility tends to be higher than backward-looking realized volatility because of a risk premium embedded in the options used
to calculate forward-looking implied volatility.</B>&nbsp;&nbsp;Therefore, the use of forward-looking implied volatility at a time of
relatively elevated implied volatility (as reflected in the VIX) is intended to use the volatility measure that is expected to be the
higher of the two, with the result that the exposure to the Underlying Futures Index will be lower than if the other measure were used
at a time of relatively elevated implied volatility.&nbsp;&nbsp;This is premised on the assumption that there is an inverse relationship
between performance and volatility, so that the Index will benefit from reduced exposure to the Underlying Futures Index at a time of
higher volatility.&nbsp;&nbsp;As described elsewhere, however, there can be no assurance that this relationship will hold over any particular
time period, and the Index might have performed better if it did not adjust its measure of underlying volatility in this manner.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Index has limited actual performance information.</B>&nbsp;&nbsp;The Index launched on
August 14, 2025.&nbsp;&nbsp;Accordingly, the Index has limited actual performance data.&nbsp;&nbsp;Because the Index is of recent origin
with limited performance history, an investment linked to the Index may involve a greater risk than an investment linked to one or more
indices with an established record of performance.&nbsp;&nbsp;A longer history of actual performance may have provided more reliable information
on which to assess the validity of the Index&rsquo;s methodology.&nbsp;&nbsp;However, any historical performance of the Index is not an
indication of how the Index will perform in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>Hypothetical back-tested Index performance information is subject to significant limitations.</B>&nbsp;&nbsp;All
information regarding the performance of the Index prior to August 14, 2025 is hypothetical and back-tested, as the Index did not exist
prior to that time.&nbsp;&nbsp;It is important to understand that hypothetical back-tested Index performance information is subject to
significant limitations, in addition to the fact that past performance is never a guarantee of future performance.&nbsp;&nbsp;In particular:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">o</FONT></TD><TD><FONT STYLE="background-color: white">The sponsor of the Index developed the rules of the Index with the benefit of hindsight&mdash;that
is, with the benefit of being able to evaluate how the Index rules would have caused the Index to perform had it existed during the hypothetical
back-tested period.&nbsp;&nbsp;The fact that the </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="background-color: white">Index generally appreciated
over any portion of the hypothetical back-tested period may not therefore be an accurate or reliable indication of any fundamental aspect
of the Index methodology.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">o</FONT></TD><TD><FONT STYLE="background-color: white">The hypothetical back-tested performance of the Index might look different if it covered a different
historical period.&nbsp;&nbsp;The market conditions that existed during the historical period covered by the hypothetical back-tested
Index performance information are not necessarily representative of the market conditions that will exist in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">o</FONT></TD><TD><FONT STYLE="background-color: white">SPXW options were not published as frequently prior to May 11, 2022 as they are now, and as
a result the calculation of the hypothetical back-tested values of the Index prior to that date differs from the calculation of the Index
today.&nbsp;&nbsp;The hypothetical back-tested performance of the Index prior to May 11, 2022 may therefore differ from how the Index
would have performed if SPXW options had been available with expirations on every weekday, as they are now.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">It is impossible to
predict whether the Index will rise or fall. The actual future performance of the Index may bear no relation to the historical or hypothetical
back-tested levels of the Index.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>An affiliate of ours participated in the development of the Index.</B>&nbsp;&nbsp;CGMI worked
with the sponsor of the Index in developing the guidelines and policies governing the composition and calculation of the Index, and in
that role made judgments and determinations about the Index methodology.&nbsp;&nbsp;Although CGMI no longer has a role in making any judgments
and determinations relating to the Index, the judgments and determinations previously made by CGMI could continue to have an impact, positive
or negative, on the level of the Index and the value of your securities.&nbsp;&nbsp;CGMI was under no obligation to consider your interests
as an investor in the securities in its role in developing the guidelines and policies governing the Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>Changes that affect the Index may affect the value of your securities.</B>&nbsp;&nbsp;The
sponsor of the Index may at any time make methodological changes or other changes in the manner in which it operates that could affect
the value of the Index.&nbsp;&nbsp;We are not affiliated with the Index sponsor and, accordingly, we have no control over any changes
such sponsor may make.&nbsp;&nbsp;Such changes could adversely affect the performance of the Index and the value of and your return on
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Terms of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Market disruption events.&nbsp;</B>For purposes of determining whether
a market disruption event occurs with respect to the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER,
each reference to the &ldquo;Underlying Index&rdquo; in the section &ldquo;Description of the Securities&mdash;Certain Additional Terms
for Securities Linked to an Underlying Index&mdash;Definitions of Market Disruption Event and Scheduled Trading Day and Related Definitions&rdquo;
in the accompanying product supplement in the definition of Market Disruption Event (and defined terms used in the definition of Market
Disruption Event) shall be deemed replaced with a reference to the &ldquo;Underlying Index, the S&amp;P 500 Futures Excess Return Index
or the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index&rdquo;.&nbsp;&nbsp;References in the section &ldquo;Description of the Securities&mdash;Certain
Additional Terms for Securities Linked to an Underlying Index&mdash;Definitions of Market Disruption Event and Scheduled Trading Day and
Related Definitions&rdquo; in the accompanying product supplement to the securities comprising an Underlying Index (or any other index)
shall be deemed to include futures contracts comprising an Underlying Index (or any other index), and each reference to &ldquo;at any
time during the one-hour period that ends at the Closing Time&rdquo; shall be deemed to be replaced by a reference to &ldquo;at any time
during the trading day&rdquo;.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Material modification of the S&amp;P 500 Dynamic Participation Index.</B>
If the sponsor of the S&amp;P 500 Dynamic Participation Index announces that it will make, or that it will undertake a consultation with
respect to, a material change in the formula for or the method of calculating the S&amp;P 500 Dynamic Participation Index or any other
material modification of the S&amp;P 500 Dynamic Participation Index (other than a modification prescribed in that formula or method to
maintain the index in the event of changes in constituent stock and capitalization and other routine events) (any such announcement, a
&ldquo;material modification event&rdquo;), then the issuer may, at its option, direct the calculation agent to calculate the closing
level of the S&amp;P 500 Dynamic Participation Index on each date of determination after the effective date of such change in accordance
with the formula for and method of calculating the S&amp;P 500 Dynamic Participation Index last in effect prior to the change. Such level,
as calculated by the calculation agent, will be the closing value of the S&amp;P 500 Dynamic Participation Index for all purposes. The
terms set forth in this paragraph supersede the terms set forth in the accompanying product supplement with respect to the S&amp;P 500
Dynamic Participation Index to the extent they are inconsistent with such terms. For purposes of determining whether there has been a
material modification to the S&amp;P 500 Dynamic Participation Index, a material modification to the S&amp;P 500<SUP>&reg;</SUP> Index
shall be treated as though it were a material modification to the S&amp;P 500 Dynamic Participation Index. Furthermore, any modification
to the S&amp;P 500 Dynamic Participation Index will be treated as a material modification unless made under the following circumstances:
(i) to exercise routine judgment in the administration of the rules, provided that such routine judgment will not include deviations or
alterations to the rules designed to improve the financial performance of the index; (ii) to correct errors in implementation of the rules
or calculations made pursuant to the rules; or (iii) to make an adjustment to respond to an unanticipated event outside of the control
of the sponsor of the S&amp;P 500 Dynamic Participation Index, such as a stock split, merger, listing or delisting, nationalization, or
insolvency of a component of the index, a disruption in the financial markets for specific assets or in a particular jurisdiction, regulatory
compliance requirement, force majeure or any other unanticipated event of similar magnitude and significance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If, on any day during the term of the securities, the calculation agent
determines that a material modification event has occurred, we will have the right, but not the obligation, to redeem the securities,
in whole and not in part, by providing written notice of our election to exercise that right to the trustee (the date of such notice,
the &ldquo;early redemption notice date&rdquo;) on a redemption date of our election that is no later than the 30th business day immediately
following the early redemption notice date or earlier than the fifth business day following the early redemption notice date. A material
modification event need not be continuing on the early redemption notice date or on the redemption date. The amount due and payable on
the securities upon such redemption will be equal to the early redemption amount determined as of the early redemption notice date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">The &ldquo;early redemption amount&rdquo; will be
the fair value of the securities determined by the calculation agent as of the early redemption notice date in good faith and in a manner
based upon (but not necessarily identical to) CGMI&rsquo;s then contemporaneous practices for determining a secondary market bid price
for the securities and similar instruments. In determining the early redemption amount, the calculation agent may take into account proprietary
pricing models and may make adjustments to those models or inputs to those models in good faith and in a commercially reasonable manner.
The calculation agent may also take into account other facts, whether or not unique to us or our affiliates, in determining the early
redemption amount so long as it is in good faith and commercially reasonable. The early redemption amount may result in a significant
loss on your securities. See &ldquo;Summary Risk Factors&mdash;If a material modification event occurs during the term of the securities,
we may redeem the securities early for an amount that may result in a significant loss on your investment&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Back-Tested and Historical Performance
Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">This section contains hypothetical
back-tested performance information for the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER calculated
by S&amp;P Dow Jones Indices LLC.&nbsp;&nbsp;All S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER performance
information prior to August 14, 2025 is hypothetical and back-tested, as the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement
Index (USD) ER did not exist prior to that date.&nbsp;&nbsp;Hypothetical back-tested performance information is subject to significant
limitations.&nbsp;&nbsp;The sponsor of the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER developed
the rules of the index with the benefit of hindsight&mdash;that is, with the benefit of being able to evaluate how the rules would have
caused the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER to perform had it existed during the hypothetical
back-tested period.&nbsp;&nbsp;The fact that the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER appreciated
at any time during the hypothetical back-tested period may not therefore be an accurate or reliable indication of any fundamental aspect
of the index methodology.&nbsp;&nbsp;Furthermore, the hypothetical back-tested performance of the S&amp;P 500 Futures 40% Intraday Edge
Volatility TCA 6% Decrement Index (USD) ER might look different if it covered a different historical period.&nbsp;&nbsp;The market conditions
that existed during the hypothetical back-tested period may not be representative of market conditions that will exist in the future.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">In addition, the SPXW options
used by the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER to determine the implied volatility of the
S&amp;P 500<SUP>&reg;</SUP> Index have traded with expirations on every weekday only since May 11, 2022.&nbsp;&nbsp;When SPXW options
were first launched in 2005, only Friday expirations were available.&nbsp;&nbsp;Wednesday expirations were added on February 23, 2016;
Monday expirations were added on August 15, 2016; Tuesday expirations were added on April 18, 2022; and Thursday expirations were added
on May 11, 2022.&nbsp;&nbsp;For purposes of calculating the hypothetical back-tested performance of the Index, the implied volatility
for the one-week period ending on a weekday for which no SPXW option was then traded was calculated by interpolating between the SPXW
options expiring immediately before and immediately after that weekday.&nbsp;&nbsp;For these reasons, the hypothetical back-tested performance
of the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER prior to May 11, 2022 may differ from how the
S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER would have performed if SPXW options had been available
with expirations on every weekday, as they are now.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">It is impossible to predict whether
the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER will rise or fall.&nbsp;&nbsp;By providing the hypothetical
back-tested and historical performance information below, we are not representing that the S&amp;P 500 Futures 40% Intraday Edge Volatility
TCA 6% Decrement Index (USD) ER is likely to achieve gains or losses similar to those shown.&nbsp;&nbsp;In fact, there are frequently
sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular investment.&nbsp;&nbsp;One
of the limitations of hypothetical performance information is that it did not involve financial risk and cannot account for all factors
that would affect actual performance.&nbsp;&nbsp;The actual future performance of the S&amp;P 500 Futures 40% Intraday Edge Volatility
TCA 6% Decrement Index (USD) ER may bear no relation to its hypothetical back-tested or historical performance.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the S&amp;P 500 Futures 40% Intraday Edge Volatility
TCA 6% Decrement Index (USD) ER on October 24, 2025 was 10,060.15. The graph below shows the hypothetical back-tested closing values of
the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER for the period from January 2, 2015 to August 13,
2025, and historical closing values of the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER for the period
from August 14, 2025 to October 24, 2025.&nbsp;&nbsp;All data to the left of the vertical red line in the graph below are hypothetical
and back-tested.&nbsp;&nbsp;We obtained the closing values from Bloomberg L.P., without independent verification.&nbsp;&nbsp;<B>You should
not take the hypothetical back-tested and historical values of the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index
(USD) ER as an indication of future performance</B>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER &ndash; Hypothetical Back-Tested and Historical Closing Values</B></FONT><B><FONT STYLE="font-size: 10pt; color: white"><BR>
</FONT></B><B><FONT STYLE="font-size: 10pt; color: #59AE43">January 2, 2015 to October 24, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 319px; width: 556px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Comparison of Hypothetical Back-Tested and Historical S&amp;P 500
Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER Performance Against Historical S&amp;P 500<SUP>&reg;</SUP> Index
Performance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graphs set forth a comparison of the hypothetical back-tested
and historical performance of the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER against the historical
performance of the S&amp;P 500<SUP>&reg;</SUP> Index.&nbsp;&nbsp;The first graph shows comparative performance data for the period from
January 2, 2015 through October 24, 2025, each normalized to have a closing value of 100.00 on January 2, 2015 to facilitate a comparison.&nbsp;&nbsp;The
second graph shows comparative performance data for the period from January 3, 2022 through October 24, 2025, each normalized to have
a closing value of 100.00 on January 3, 2022 to facilitate a comparison.&nbsp;&nbsp;The performance of the S&amp;P 500<SUP>&reg;</SUP>
Index shown below is its price return performance &ndash; i.e., its performance without reflecting dividends. The total return performance
of the S&amp;P 500<SUP>&reg;</SUP> Index (i.e., its performance reflecting dividends) would be greater than the price return performance
shown below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">All S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement
Index (USD) ER performance information prior to August 14, 2025 is hypothetical and back-tested, as the S&amp;P 500 Futures 40% Intraday
Edge Volatility TCA 6% Decrement Index (USD) ER did not exist prior to that date.&nbsp;&nbsp;Hypothetical back-tested performance information
is subject to the significant limitations described above under &ldquo;Information About the S&amp;P 500 Futures 40% Intraday Edge Volatility
TCA 6% Decrement Index (USD) ER&rdquo;.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the graphs below, references to &ldquo;SPXI4EV6&rdquo; are to the
S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER and references to &ldquo;SPX&rdquo; are to the S&amp;P
500<SUP>&reg;</SUP> Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>January 2, 2015 to October 24, 2025</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 287px; width: 480px"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>January 3, 2022 to October 24, 2025</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><IMG SRC="image_003.jpg" ALT="" STYLE="height: 286px; width: 479px"></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>PAST PERFORMANCE OF THE S&amp;P 500 FUTURES 40% INTRADAY EDGE
VOLATILITY TCA 6% DECREMENT INDEX (USD) ER AND RELATIVE PERFORMANCE BETWEEN THE S&amp;P 500 FUTURES 40% INTRADAY EDGE VOLATILITY TCA 6%
DECREMENT INDEX (USD) ER AND THE S&amp;P 500<SUP>&reg;</SUP> INDEX ARE NOT INDICATIVE OF FUTURE PERFORMANCE</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Using the hypothetical back-tested and historical performance information
from the graphs above, the table below shows the annualized (annually compounded) performance of the S&amp;P 500 Futures 40% Intraday
Edge Volatility TCA 6% Decrement Index (USD) ER as compared to the S&amp;P 500<SUP>&reg;</SUP> Index for the last year, the last three
years and the last five years, each as of October 24, 2025.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD STYLE="width: 21%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER</B></FONT></TD>
    <TD STYLE="width: 43%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 1 Year</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">17.12%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">16.90%</FONT></TD></TR>
  <TR STYLE="background-color: #EAF3E0">
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 3 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">47.76%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">21.36%</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 5 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">26.63%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">14.39%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The table below indicates the negative impact of the notional costs
on the performance of the S&amp;P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER based on the hypothetical back-tested
and historical information from the graphs above.&nbsp;&nbsp;In the future, the negative impact of these notional costs may be greater,
and perhaps significantly greater, than the values set forth below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD STYLE="width: 21%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Average per annum</B></FONT></TD>
    <TD STYLE="width: 43%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Maximum amount over any annual period</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Notional costs</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">2.00%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">2.71%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Comparison of Historical S&amp;P 500 Futures Excess Return Index
Performance Against Historical S&amp;P 500<SUP>&reg;</SUP> Index Performance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">To illustrate the historical impact of the implicit financing cost on
the performance of the S&amp;P 500 Futures Excess Return Index, the following graph sets forth a comparison of the historical performance
of the S&amp;P 500 Futures Excess Return Index against the historical performance of the S&amp;P 500<SUP>&reg;</SUP> Index from January
2, 2015 through October 24, 2025, each normalized to have a closing value of 100.00 on January 2, 2015 to facilitate a comparison.&nbsp;&nbsp;The
performance of the S&amp;P 500<SUP>&reg;</SUP> Index shown below is its price return performance &ndash; i.e., its performance without
reflecting dividends.&nbsp;&nbsp;The total return performance of the S&amp;P 500<SUP>&reg;</SUP> Index (i.e., its performance reflecting
dividends) would be greater than the price return performance shown below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the graph below, references to &ldquo;SPXFP&rdquo; are to the S&amp;P
500 Futures Excess Return Index and references to &ldquo;SPX&rdquo; are to the S&amp;P 500<SUP>&reg;</SUP> Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>January 2, 2015 to October 24, 2025</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 305px; width: 509px"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>PAST PERFORMANCE OF THE S&amp;P 500 FUTURES EXCESS RETURN INDEX
AND RELATIVE PERFORMANCE BETWEEN THE S&amp;P 500 FUTURES EXCESS RETURN INDEX AND THE S&amp;P 500<SUP>&reg;</SUP> INDEX ARE NOT INDICATIVE
OF FUTURE PERFORMANCE</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Using the historical performance information from the graph above, the
table below shows the annualized (annually compounded) performance of the S&amp;P 500 Futures Excess Return Index as compared to the S&amp;P
500<SUP>&reg;</SUP> Index for the last year, the last three years and the last five years, each as of October 24, 2025.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD STYLE="width: 21%">&nbsp;</TD>
    <TD STYLE="width: 36%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>S&amp;P 500 Futures Excess Return Index</B></FONT></TD>
    <TD STYLE="width: 43%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 1 Year</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">12.35%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">16.90%</FONT></TD></TR>
  <TR STYLE="background-color: #EAF3E0">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 3 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">16.58%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">21.36%</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 5 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">11.99%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">14.39%</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the securities.&nbsp;&nbsp;In connection with any information
reporting requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination
or judicial ruling to the contrary) to treat the securities for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting.&nbsp;&nbsp;In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions,
this treatment of the securities is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively
that this treatment is more likely than not to be upheld, and that alternative treatments are possible.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Any coupon payments on the securities should be taxable as ordinary income to you at the time received or accrued in accordance with
your regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the security.&nbsp;&nbsp;For this purpose, the amount realized does not include any
coupon paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment.&nbsp;&nbsp;Such
gain or loss should be long-term capital gain or loss if you held the security for more than one year.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">We do not plan to request a ruling
from the IRS regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely
affect the tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In
addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar financial instruments and have indicated that such transactions may be the subject
of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative
contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and
adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax
adviser regarding possible alternative tax treatments of the securities and potential changes in applicable law. </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders. </B>Because significant aspects
of the tax treatment of the securities are uncertain, persons having withholding responsibility in respect of the securities may withhold
on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the
extent that we have (or an affiliate of ours has) withholding responsibility in respect of the securities, we intend to so withhold.&nbsp;&nbsp;In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any amounts withheld
and the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">As discussed under &ldquo;United
States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m)
of the Code and Treasury regulations promulgated thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend
equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S.
Underlying Equities&rdquo;) or indices that include U.S. Underlying Equities.&nbsp;&nbsp;Section 871(m) generally applies to instruments
that substantially replicate the economic performance of one or more U.S. Underlying Equities, as determined based on tests set forth
in the applicable Treasury regulations.&nbsp;&nbsp;However, the regulations, as modified by an IRS notice, exempt financial instruments
issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.&nbsp;&nbsp;Based on the terms of the securities and representations
provided by us, our counsel is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo;
of one within the meaning of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding
tax under Section 871(m). </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">A determination that the securities
are not subject to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section
871(m) is complex and its application may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should
consult your tax adviser regarding the potential application of Section 871(m) to the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $12.50 for each security sold
in this offering (or up to $12.50 for each security in the case of sales to fee-based advisory accounts). From this underwriting fee,
CGMI will pay selected dealers not affiliated with CGMI a fixed selling concession of $12.50 for each security they sell to accounts other
than fee-based advisory accounts. CGMI will pay selected dealers not affiliated with CGMI, which may include dealers acting as custodians,
a variable selling concession of up to $12.50 for each security they sell to fee-based advisory accounts. For the avoidance of doubt,
any fees or selling concessions described in this pricing supplement will not be rebated if the securities are automatically redeemed
prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately four months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the four-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Validity of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In addition,
this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has
been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly
authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of
the securities nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets
Holdings Inc. and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of
any provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable,
or any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #59AE40 1pt solid; width: 100%; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">natural persons, the genuineness of all signatures (other than those
of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents submitted to her or such persons as originals,
the conformity to original documents of all documents submitted to her or such persons as certified or photostatic copies and the authenticity
of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.&nbsp;&nbsp;This
opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236412_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B8</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-28</xbrli:startDate>
          <xbrli:endDate>2025-10-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-28</xbrli:startDate>
          <xbrli:endDate>2025-10-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-10-28</xbrli:startDate>
          <xbrli:endDate>2025-10-28</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">1,395</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">1,395,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">192.65</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">1,395,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">192.65</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">192.65</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">1,395,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $_ BP# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BH#>6H)!N800<$;Q1]MM?\ GYA_[^"@">BH/MMK_P _,/\ W\%'
MVVU_Y^8?^_@H GHJ#[;:_P#/S#_W\%'VVU_Y^8?^_@H GHJ#[;:_\_,/_?P4
M?;;7_GYA_P"_@H GHJ#[;:_\_,/_ '\%'VVU_P"?F'_OX* )Z*@^VVO_ #\P
M_P#?P4?;;7_GYA_[^"@">BH/MMK_ ,_,/_?P4?;;7_GYA_[^"@">BH/MMK_S
M\P_]_!1]MM?^?F'_ +^"@">BH/MMK_S\P_\ ?P4?;;7_ )^8?^_@H GHJ#[;
M:_\ /S#_ -_!1]MM?^?F'_OX* )Z*@^VVO\ S\P_]_!1]MM?^?F'_OX* )Z*
M@^VVO_/S#_W\%'VVU_Y^8?\ OX* )Z*@^VVO_/S#_P!_!1]MM?\ GYA_[^"@
M">BH/MMK_P _,/\ W\%'VVU_Y^8?^_@H GHJ#[;:_P#/S#_W\%'VVU_Y^8?^
M_@H GHJ#[;:_\_,/_?P4?;;7_GYA_P"_@H GHJ#[;:_\_,/_ '\%'VVU_P"?
MF'_OX* )Z*@^VVO_ #\P_P#?P4?;;7_GYA_[^"@">BH/MMK_ ,_,/_?P4?;;
M7_GYA_[^"@">BH/MMK_S\P_]_!1]MM?^?F'_ +^"@">BH/MMK_S\P_\ ?P4?
M;;7_ )^8?^_@H GHJ#[;:_\ /S#_ -_!1]MM?^?F'_OX* )Z*@^VVO\ S\P_
M]_!1]MM?^?F'_OX* )Z*@^VVO_/S#_W\%'VVU_Y^8?\ OX* )Z*@^VVO_/S#
M_P!_!1]MM?\ GYA_[^"@">BH/MMK_P _,/\ W\%'VVU_Y^8?^_@H GHJ#[;:
M_P#/S#_W\%'VVU_Y^8?^_@H GHJ#[;:_\_,/_?P4?;;7_GYA_P"_@H GHJ#[
M;:_\_,/_ '\%'VVU_P"?F'_OX* )Z*@^VVO_ #\P_P#?P4?;;7_GYA_[^"@"
M>BH/MEK_ ,_,/_?P4Y+FWD<*D\3,>@5P30!+1110 4444 %%%% !1110!SVG
M1H;%28T)WR?PC_GHU6O+C_YYI_WR*KZ;_P >"?[\G_H;5:H ;Y<?_/-/^^11
MY<?_ #S3_OD4ZB@!OEQ_\\T_[Y%'EQ_\\T_[Y%.HH ;Y<?\ SS3_ +Y%'EQ_
M\\T_[Y%.HH ;Y<?_ #S3_OD4>7'_ ,\T_P"^13J* &^7'_SS3_OD4>7'_P \
MT_[Y%.HH ;Y<?_/-/^^11Y<?_/-/^^13J* &^7'_ ,\T_P"^11Y<?_/-/^^1
M3J* &^7'_P \T_[Y%'EQ_P#/-/\ OD4ZB@!OEQ_\\T_[Y%'EQ_\ /-/^^13J
M* &^7'_SS3_OD4>7'_SS3_OD4ZB@!OEQ_P#/-/\ OD4>7'_SS3_OD4ZB@!OE
MQ_\ /-/^^11Y<?\ SS3_ +Y%.HH ;Y<?_/-/^^11Y<?_ #S3_OD4ZB@!OEQ_
M\\T_[Y%'EQ_\\T_[Y%.HH ;Y<?\ SS3_ +Y%'EQ_\\T_[Y%.HH ;Y<?_ #S3
M_OD4>7'_ ,\T_P"^13J* &^7'_SS3_OD4>7'_P \T_[Y%.HH ;Y<?_/-/^^1
M1Y<?_/-/^^13J* &^7'_ ,\T_P"^11Y<?_/-/^^13J* &^7'_P \T_[Y%'EQ
M_P#/-/\ OD4ZB@!OEQ_\\T_[Y%'EQ_\ /-/^^13J* &^7'_SS3_OD4>7'_SS
M3_OD4ZB@!OEQ_P#/-/\ OD4>7'_SS3_OD4ZB@!OEQ_\ /-/^^11Y<?\ SS3_
M +Y%.HH ;Y<?_/-/^^11Y<?_ #S3_OD4ZB@!OEQ_\\T_[Y%'EQ_\\T_[Y%.H
MH ;Y<?\ SS3_ +Y%'EQ_\\T_[Y%.HH ;Y<?_ #S3_OD4>7'_ ,\T_P"^13J*
M &^7'_SS3_OD4>7'_P \T_[Y%.HH PK=$_X3G4!L7']G0'&T8^^];*HBWMF0
MB@^:>0 /X&K'M_\ D>M0_P"P=!_Z&]&GZK<7?C&6Q;:+>W<[!CG.TYYK&,U'
M1]6SIQDE&5-=XQ_)G8T445L<P4444 4;^6XBN;'RI L;S;)%VY+ J3U[=*S[
M2_N3#<L)?.D$ ?:V/DF^;Y!CZ#CK6]36C1L94'!W#COZT <XU_.$<+?L8%!:
M*?*Y>3:"$Z8/)/'7M5RPN[B74=LDA9B'\V#C]U@C;[C(SUK8VC&,"EP,YQR:
M .;TZ27[ G^CM]^3^-?[[5:\R7_GW;_OM:BTW_CP3_?D_P#0VJU0!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!%YDO_ #[M_P!]K1YDO_/NW_?:U+10!%YDO_/N
MW_?:T>9+_P ^[?\ ?:U+10!SL4DH\::DPA8,--AXWCCYWYK"\&32-XKAW,6,
MH<N3U)VDUN2L4\5:TXZKI$9'_?4E<_X)_P"1JM/]U_\ T$UYU1_O8+S8LQ?[
M^BO[L?R/6****]$84444 %%!Z<5SUG<WJI>)EBPB 1W8G?/\V0,CCH.* .AH
MKF&EE\M]D]U]EP?)?+;C+M& >^,Y]LU=L'N6U(B1Y#)A_/0D[5Y&S';IGI0!
M%IO_ !X)_OR?^AM5JL_3FN/L"?NH_OR?Q_[;>U6]UQ_SRC_[[/\ A0!+146Z
MX_YY1_\ ?9_PHW7'_/*/_OL_X4 2T5%NN/\ GE'_ -]G_"C=<?\ /*/_ +[/
M^% $M%1;KC_GE'_WV?\ "C=<?\\H_P#OL_X4 2T5%NN/^>4?_?9_PHW7'_/*
M/_OL_P"% $M%1;KC_GE'_P!]G_"C=<?\\H_^^S_A0!+146ZX_P">4?\ WV?\
M*-UQ_P \H_\ OL_X4 2T5%NN/^>4?_?9_P *-UQ_SRC_ .^S_A0!+146ZX_Y
MY1_]]G_"C=<?\\H_^^S_ (4 2T5%NN/^>4?_ 'V?\*-UQ_SRC_[[/^% $M%1
M;KC_ )Y1_P#?9_PHW7'_ #RC_P"^S_A0!+146ZX_YY1_]]G_  HW7'_/*/\
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M'_&I:* (O])]8?R/^-'^D^L/Y'_&I:* (O\ 2?6'\C_C1_I/K#^1_P :EHH
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M#&?2I$NH))W@29&E3ED!Y% &-IO_ !X)_OR?^AM5JJNF_P#'@G^_)_Z&U6J
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MEHH B\@_\]YO^^A_A1Y!_P">\W_?0_PJ6B@"+R#_ ,]YO^^A_A1Y!_Y[S?\
M?0_PJ6B@"+R#_P ]YO\ OH?X4>0?^>\W_?0_PJ6B@"+R#_SWF_[Z'^%'D'_G
MO-_WT/\ "I:* (O(/_/>;_OH?X4>0?\ GO-_WT/\*EHH B\@_P#/>;_OH?X4
M>0?^>\W_ 'T/\*EHH B\@_\ />;_ +Z'^%'D'_GO-_WT/\*EHH B\@_\]YO^
M^A_A1Y!_Y[S?]]#_  J6B@"+R#_SWF_[Z'^%'D'_ )[S?]]#_"I:* (O(/\
MSWF_[Z'^%'D'_GO-_P!]#_"I:* (O(/_ #WF_P"^A_A1Y!_Y[S?]]#_"I:*
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MI<'T-&#Z&@!**7!]#1@^AH 2BEP?0T8/H: $HI<'T-&#Z&@!**7!]#1@^AH
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M/7GO70;5_NK^551PMXWJ[_Y#I8:ZO5W_ ,CF?%%A)?VEE#8^7((20<RJ,#
MZFKFE:396)@NI)(_MJPB-RL@V],<?XUM;5_NK^5&U?[J_E75[&'/S]3I]E'G
MY^HS[1#_ ,]H_P#OL4C2VSC:\D+*>H9@0:DVK_=7\J-J_P!U?RK8U.4\,6RV
M>KZHTBB(!ML9+#:1N)X/?M74?:(?^>T?_?8I^U?[H_*C:O\ =7\JSITU3CRH
MBG!0CRH9]HA_Y[1_]]BC[1#_ ,]H_P#OL4_:O]U?RHVK_=7\JT+&?:(?^>T?
M_?8H^T0_\]H_^^Q3]J_W5_*C:O\ =7\J &?:(?\ GM'_ -]BC[1#_P ]H_\
MOL4_:O\ =7\J-J_W5_*@!GVB'_GM'_WV*/M$/_/:/_OL4_:O]U?RHVK_ '5_
M*@#!MYHO^$YU!O-3']G0#.X?WWK:26-[ZS"2(Q\P\!@?X&K'MU7_ (3K4/E'
M_(.@[?[;UM!0+VSP /WIZ#_8:LZ>S]6=>+^*'^&/Y,V****T.0**** "BBL\
M:A+$;LW$*A8(_,S&V[CGY3QUX_6@#0HK&;5[E#)$;>+SXE,K@.=NP '@XZ\X
MJ>TU-KFZ53&JPR!S&V3N^4@'(QQUH I:;_QX)_OR?^AM5JL_3KJ#[ G[U?OR
M?^AM5K[5!_SU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5H^U0?\]5H FHJ'
M[5!_SU6C[5!_SU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5H^U0?\]5H FH
MJ'[5!_SU6C[5!_SU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5KE=0U(/XVL
MQ%-B*+:CG/'.<Y_.LJE14TF^KL9U*B@DWW.PHJ$7=N1D3*0>A%'VJ#_GJM:F
MA-16/KFN1Z;8-);R1/<DC8C'MGDX[BL/PUX@N[C5FAO;@O%*K, 1]TCL/0=:
MPE7A&HJ?5F,JT8S4.K.THJ'[5!_SU6C[5!_SU6MS8FHK#U3Q/::;<10JOGLW
MWRC?ZOGO67XLUF4R1Z=9,X#@.SH3EL] .]83KPBF][&,ZT8IO>QV%(2%4LQ"
MJ!DD] *Y_P )W<?]A*DLQ+I(P(<DX]J@\6ZMMM$T^U;=+<\/@?P^GXFAUDJ7
MM =5*G[0R;C3[GQ-K&HW%K(OE0G:A<\'L /RS5_PG;2Z?K5_93[?-6)2P!R,
MY_\ KU=\*V_]FZ8XN6\N663<8R.5QQ6)X@:?3_$+ZC;L2DHP'![[<$5Q<GLU
M&NUK?7YW.3DY$JS6M]?Q.LUC4X].TZYE66/ST7"H2,[CTXKBK_Q)?ZI8QV7'
MSC$I5?\ 6'/'T'2H;'0[J^:WG=U\B4_-(S995'J*[33M-TO2[B>:V<YEP,-R
M%'H*K]]B'_+$K][7\D:-E;_9+&WMQC]U&%./7'-2K&B%BB*I8Y8@8R?>H_M4
M'_/5:/M4'_/5:]%))6.Y)+0FHJ'[5!_SU6C[5!_SU6F,FHJ'[5!_SU6C[5!_
MSU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5H^U0?\]5H FHJ'[5!_SU6C[5
M!_SU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5H^U0?\]5H FHJ'[5!_SU6C
M[5!_SU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5H^U0?\]5H FHJ'[5!_SU
M6C[5!_SU6@":BH?M4'_/5:/M4'_/5: )J*A^U0?\]5H^U0?\]5H R;?_ )'K
M4/\ L'0?^AO6T/\ C]L_^NI_] :L&WN(?^$XU!O,&#IT S_P-ZVHYXI+ZS5'
M#'S"<#_<:LZ>S]6=>+^*'^&/Y,VZ***T.0**** "J<6FP0HR1M+L9MS*TK.&
MZY')/!S5RB@"E_9-GY8CV.0#G)D;)XQ@G.2, #'2I8K*"&X:=$(=O]HD#/7
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MGG!S]*U?"\5UJNIQ7URWF0V2>6C-SSV'N1G-=Q@>@_*HXH(8%*PQ)&I.2$4
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M+/49KBZ0,BB&42; %.Y=A Y]<YJS_9EEY*Q?9D\M6W@>]2I:P17#SI$JRO\
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M_%4GVM]^S[#>;L9QL7_XJ@"S15:2[>)"[V-XJCU1?_BJ<+B4C(L+P@]PB_\
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MR2.2XW$L,Y48'.!["@#GXX[:&SCO)H+E"]Q&(YV8,['S,8/]QCD9]0,5K:Y
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M:?/J=LD$:0,@;<WFL1@CIC .>IZUJT4 8?AN!K72IE6)_,\YSE_E$AX&1P,
MXQT[$UCV6E-<Z]G4]*^R+N^T)Y1=E:9MV[YPV!Q@]!G)KM** *%_I-I?DR31
M;Y0N%R[ #\ 14,EM?VGAXV]M,9KQ$PKX )YY SZ#(&?;-:M% '/Z1;&'5&DM
M(+I+=XS]H:[3#,^1MP3R?XL]NE0>(]*N+N22[*0>7%'M4C+.1Z;=I&>2/QYK
MIZ* ,2_MII/#D%G!IHN(WC2.2">3!1,?J1@=Q5;PK8)'%+>3VSP:A)\LZ%77
M;CH/F)W<=\FNDHH QYM @\^*>T)@F$H=Y2[,V.I R<<]/H:;K<<LTT4<R7#Z
M<R,)%MAEB^1C<!SMQGIWZUM44 9>BQ7,.EM&\>P*[?9TD #!/X=V._\ GK6-
M;:/+9^(+66:%"7D>3%N20APWS,2HX^<C&><CKBNMHH YGQ5#?3-$UOI27*PC
M<DP9BZ,3AL*K*?N^Y^E:&G:/I\6BI9PQO]F8;B"60D_3.1]*UJ* ,VPTE=/O
M9I(&V6SH%6$$GGNQ))Y[<5C7UM=37$[RP7<FH)*QLV5 8%7/R\G@#USSUQVK
MJZ* ,[5K.XO].^S1K Q<C?YC$ 8YXP#W ZU1\,V1LC?1M&P82*I<<(V!@!>!
MG'3/?UK?HH XJ73);WQ /[3TD6]O,_F/)$7D#R*5"98-A<COM'0<UU-WI5G>
MK&MQ$SB,84>8P_D>:N44 9EM97=AHT\$$JR7.',((^5"?NKSDX'O6;IMM(FJ
MP3P07JRL"+R2[0#(V]CW.['W>,9]JZ6B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K,UKP]I'B*"*#5["&\CB?>BRC[K8QD?A6G10!A3^#/#=S96UG-
MHEDUM:JRP1^4 $#?> ^O>G2^#_#TR7"2:3;%;B199?E^\ZC ;V..,BMNB@".
MWMX;6WCM[>-8X8U"HBC 4#H!4E%% !1110 4444 %%%% !1110 4444 %%%%
H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $? > # 2(  A$! Q$!_\0
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M^/\ S(HD1Y].9I648,A$B@%O4@<4 ;GD0_\ /)/^^11Y$/\ SR3_ +Y%244
M1^1#_P \D_[Y%'D0_P#/)/\ OD5)10!'Y$/_ #R3_OD4>1#_ ,\D_P"^14E%
M $?D0_\ /)/^^11Y$/\ SR3_ +Y%244 1^1#_P \D_[Y%'D0_P#/)/\ OD5)
M10!'Y$/_ #R3_OD4>1#_ ,\D_P"^14E% $?D0_\ /)/^^11Y$/\ SR3_ +Y%
M244 1^1#_P \D_[Y%'D0_P#/)/\ OD5)10!'Y$/_ #R3_OD4>1#_ ,\D_P"^
M14E% $?D0_\ /)/^^11Y$/\ SR3_ +Y%244 1^1#_P \D_[Y%'D0_P#/)/\
MOD5)10!'Y$/_ #R3_OD4>1#_ ,\D_P"^14E% $?D0_\ /)/^^11Y$/\ SR3_
M +Y%244 1^1#_P \D_[Y%'D0_P#/)/\ OD5)10!'Y$/_ #R3_OD4>1#_ ,\D
M_P"^14E% $?D0_\ /)/^^11Y$/\ SR3_ +Y%244 1^1#_P \D_[Y%'D0_P#/
M)/\ OD5)10!'Y$/_ #R3_OD4>1#_ ,\D_P"^14E% $?D0_\ /)/^^11Y$/\
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M +!C_P#HU* -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0GO?&>@^ +"+-Q?ZC'Y\L:8#']VNY\= ,%S^%>X6MO'9VD-M",10HL:#T4#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2Z7-;EE0L<^8A' ^M:'P[E6]U#Q?J$>3%/K4BHQ'W@B*O'Y5K.3=ZK6Z_P"
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MY5)4<_\ Q[R?[A_E0 0\V\?^X/Y4D5M! Q:*".-CU*( 32P?\>\?^X/Y5)0
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MO:+P<0J6)]1D^E &[4;W$$>[?-&NT9.6 Q6,^@W:CS(-9NQ.>K.<@CTQ2_\
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M^DVU_8K:,/+1""A0 ;<>GX5?HH Y70M)GGE\W5(W*6W[NWCEZ=3DX[]L&NJ
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M**CV2_\ /7_QVD"3<YE'7CY: ):*CV2_\]?_ !VC9+_SU_\ ': )**CV2_\
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M<- 0R ;1E2#W).!U P3GL=VB@#/T0W9T6T^W>;]J$8$OF@!B1W../RK0HHH
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MQCKTU% "*25!(P<<CTI:** "HY_^/>3_ '#_ "J2HY_^/>3_ '#_ "H (/\
MCWC_ -P?RJ2JL5W L,:F3D* >#Z4_P"VV_\ ST_\=- $]%0?;;?_ )Z?^.FC
M[;;_ //3_P =- $]%0?;;?\ YZ?^.FC[;;_\]/\ QTT 3T5!]MM_^>G_ (Z:
M/MMO_P ]/_'30!/14'VVW_YZ?^.FC[;;_P#/3_QTT 3T5!]MM_\ GI_XZ:/M
MMO\ \]/_ !TT 3T5!]MM_P#GI_XZ:/MMO_ST_P#'30!/14'VVW_YZ?\ CIH^
MVV__ #T_\=- $]%0?;;?_GI_XZ:/MMO_ ,]/_'30!/14'VVW_P">G_CIH^VV
M_P#ST_\ '30!/14'VVW_ .>G_CIH^VV__/3_ ,=- $]<IJFE>-9]2GETWQ-8
M6MFQ_=0R:=YC(,="V[GFND^VV_\ ST_\=-'VVW_YZ?\ CIJHRL)JYQ_]B_$/
M_H<-,_\ !5_]G5IM'\2-'$MQJ,=S<-$$GG53%&</D;$#9!QP><$#J*Z;[;;_
M //3_P =-'VVW_YZ?^.FG*;8)6.:BT77K:>017[21!T,)FF8[ OWBP[AC@X[
M 8[U#:Z+X@M8[IC/YMRBAK5FN6*,RN6VL3SAAP>,<^U=7]MM_P#GI_XZ:/MM
MO_ST_P#'34#,C2-/U2QU*3[3/]HMS& )'<EL[5X _P![S"?J*WJ@^VV__/3_
M ,=-'VVW_P">G_CIH GHJ#[;;_\ /3_QTT?;;?\ YZ?^.F@">BH/MMO_ ,]/
M_'31]MM_^>G_ (Z: (;V'4)74V=W% H'S!XM^3^=5OLNM_\ 03M__ ;_ .O5
M_P"VV_\ ST_\=-'VVW_YZ?\ CIH R;VQUB2U3%VDTZ3*Z!5\M, '(?G)7G/'
M((!YZ51MM#UFWO;.<WLCQB3?=1&=MKC/ '7D'YB>,XVXP:Z3[;;_ //3_P =
M-'VVW_YZ?^.F@">BH/MMO_ST_P#'31]MM_\ GI_XZ: )Z*@^VV__ #T_\=-'
MVVW_ .>G_CIH GHJ#[;;_P#/3_QTT?;;?_GI_P".F@">BH/MMO\ \]/_ !TT
M?;;?_GI_XZ: )Z*@^VV__/3_ ,=-'VVW_P">G_CIH GHJ#[;;_\ /3_QTT?;
M;?\ YZ?^.F@">BH/MMO_ ,]/_'31]MM_^>G_ (Z: )Z*@^VV_P#ST_\ '31]
MMM_^>G_CIH GHJ#[;;_\]/\ QTT?;;?_ )Z?^.F@">BH/MMO_P ]/_'31]MM
K_P#GI_XZ: )ZCG_X]Y/]P_RIGVVW_P">G_CIJ.:\@:&0"3DJ0.#Z4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $> =\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WB&&(P1DQ
MH25'\(]*?Y$/_/)/^^11!_Q[Q_[@_E4E %2XELK1HEG54\U@B'RR1D] 2!@9
M]ZAM;_3+VX:"WP\JC++Y+ IR1\V1QR#UJ6[T]+RXMIGFE7[.Q=47&TL1C)!!
MY'./3-5K30;:UDMI!--(]N696?;N9FSDLP4$YW$]<9YQ0!H^3#_SRC_[Y%'D
MP_\ /*/_ +Y%836MNGCU)$@C5YM.D,K!0"Y$D8!;UP.!6]Y,7_/-/^^10 GD
MP_\ /*/_ +Y%'DP_\\H_^^12^3%_SS3_ +Y%'DQ?\\T_[Y% ">3#_P \H_\
MOD4>3#_SRC_[Y%+Y,7_/-/\ OD4>3%_SS3_OD4 )Y,/_ #RC_P"^11Y,/_/*
M/_OD4ODQ?\\T_P"^11Y,7_/-/^^10 GDP_\ /*/_ +Y%'DP_\\H_^^12^3%_
MSS3_ +Y%'DQ?\\T_[Y% ">3#_P \H_\ OD4>3#_SRC_[Y%+Y,7_/-/\ OD4>
M3%_SS3_OD4 )Y,/_ #RC_P"^11Y,/_/*/_OD4ODQ?\\T_P"^11Y,7_/-/^^1
M0 GDP_\ /*/_ +Y%'DP_\\H_^^12^3%_SS3_ +Y%'DQ?\\T_[Y% ">3#_P \
MH_\ OD4>3#_SRC_[Y%+Y,7_/-/\ OD4>3%_SS3_OD4 )Y,/_ #RC_P"^11Y,
M/_/*/_OD4ODQ?\\T_P"^11Y,7_/-/^^10 GDP_\ /*/_ +Y%'DP_\\H_^^12
M^3%_SS3_ +Y%'DQ?\\T_[Y% ">3#_P \H_\ OD4>3#_SRC_[Y%+Y,7_/-/\
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M7_/-/^^10 GDP_\ /*/_ +Y%'DP_\\H_^^12^3%_SS3_ +Y%'DQ?\\T_[Y%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *@O?^/1_P_G4]07O_ !Z/^'\Z 'P?\>\?
M^X/Y5)4<'_'O'_N#^524 %%%% &))_R/-M_V#9?_ $;'6W6))_R/-M_V#9?_
M $;'6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#GB_YC_&CS'_YXO^8_QJ2B@"/S'_YXO^8_QH\Q_P#GB_YC_&I** (_,?\
MYXO^8_QH\Q_^>+_F/\:DHH C\Q_^>+_F/\:/,?\ YXO^8_QJ2B@"/S'_ .>+
M_F/\:/,?_GB_YC_&I** (_,?_GB_YC_&CS'_ .>+_F/\:DHH C\Q_P#GB_YC
M_&CS'_YXO^8_QJ2B@"/S'_YXO^8_QH\Q_P#GB_YC_&I** (_,?\ YXO^8_QH
M\Q_^>+_F/\:DHH C\Q_^>+_F/\:/,?\ YXO^8_QJ2B@"/S'_ .>+_F/\:/,?
M_GB_YC_&I** (_,?_GB_YC_&CS'_ .>+_F/\:DHH C\Q_P#GB_YC_&CS'_YX
MO^8_QJ2B@"/S'_YXO^8_QH\Q_P#GB_YC_&I** (_,?\ YXO^8_QH\Q_^>+_F
M/\:DHH C\Q_^>+_F/\:/,?\ YXO^8_QJ2B@"/S'_ .>+_F/\:/,?_GB_YC_&
MI** (_,?_GB_YC_&CS'_ .>+_F/\:DHH C\Q_P#GB_YC_&CS'_YXO^8_QJ2B
M@"/S'_YXO^8_QH\Q_P#GB_YC_&I** (_,?\ YXO^8_QH\Q_^>+_F/\:DHH C
M\Q_^>+_F/\:/,?\ YXO^8_QJ2B@"/S'_ .>+_F/\:/,?_GB_YC_&I** (_,?
M_GB_YC_&CS'_ .>+_F/\:DHH C\QO^>3_F/\:^<?&GBJ\\;VB><RI%IT]U<*
MD2X#(LL<<>[GKASS[U]!:[JMOHF@WVIW3,L-M"TC%1D\#L/K7S'X9TUSX.\9
M7\Q(:"RMU1>P$LJN3^2#\Z[L+%:S?D857T/I"SUV2Z\77VBF!5CM;*"X\S/S
M%I&<$>F %'YUJWO_ !Z/^'\Z\\^'VK'Q-XY\4ZY;JQT[9;VEK+L*B14WY//?
M)/YBO0[W_CT?\/YURU(\LK&L7=7,S4[/29X;6XU2:.+R8F$3O,(]A(!+*<C#
M#;U'09JYHZ)%H]I%&DJ)'$J*)F5F( QDE20<]<CK6=KGV."SLKZXT\7LL158
MHQR^3AOD&.6R@...AYK2TAXGTNW$-K<6L:($6&X0JZ #&"*S*+M%%% &))_R
M/-M_V#9?_1L=;=8DG_(\VW_8-E_]&QUMT %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 45CP>(;>?Q;=^'EBD$]M:QW32$C:0S$8]<\?K6Q3::W ***Y?XA^(+C
MPQX(U#5+-T2[C")"77< S,!T[\$TXQ<FDA-V5SHKN[M[&TENKN>."WB4M)+(
MP55 [DFN1^(NN?9_AAJ&J:7?E#-%']FN(),$[W4 J1Z@GI7':[XJN/&GP/N;
MNYA$%V;R*TN(T!"EO-3IGG!!4U5T6:;5+;X8Z&\:R6F9KN8,,Y,&Y5!'3 S^
M>*Z84>7WI='^6IFYWT1TOP>\;7WBO1;JTU,F6\T\HIN"1F56SC(QU&W!/>O2
MJ\O^'?ANW\)>/?$>D6LLDT:VEM(9).K%C(>WY?A7J%95^7G;CL5"_+J%%%%8
MEA1110 4444 %%<WX^U6?1? VK7UI*T5TL.R!U&2)&(5<>^6%<E!\3VTCP9X
M4U'5L2O?2/;WTK##)Y>X.P4#KN X]ZUC2E)71+DD[,V?BL))_"$.G)(8UU'4
M+:SD(&3L>09_E65XV\):5X8^&GBA],CDC^T6L"NK.6 $6U5QGVZ^]<=HOBX>
M+M3T_26N+B:XG\5'4(TE!/EVJ*649Z#D=.W->U^(=$M_$F@7FCW4DD<%W'L=
MXB P&<\9^E;.]'EB^]_R(5IW9F?#_18=!\"Z39PECN@6>0MUWN-S?J<?A6_>
M_P#'H_X?SI\$*6]O'!&,)&H1?H!@4R]_X]'_  _G7-)\S;-$K*QS_B^%YO#D
M'EKET=74B)Y&4A&Z!.03TST&:V=&D\W0["3*G=;QG*DD'Y1Z\UA^,G5/#=L7
M,8C\U-^X@'&T_=R",YQVZ9K?TO9_9%GL ">0F H &-H] !^0%2,MT444 8DG
M_(\VW_8-E_\ 1L=;=8DG_(\VW_8-E_\ 1L=;= !1110 4444 %%%% !1110
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MM&3U-<%6I[25S:$>56+%07O_ !Z/^'\Z2*]@FO9K6-MTD*@OCH,]OKQ2WO\
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M_.M+6I[J]N6L;%W00(S7+]%((X7/J034M-:#,^+6-6F\Q0557C,XE)R(8_<
M<FO+?#7Q O?$'B^PTY$(6?44*ON8LT8+,6(/0X _,U@:;XDU.WT[6]$MK6XN
M;_Q1Y4MMY4G,08MQ[DK@=@ /2O5O!?PIM-!U#1=?>26+4(;4_:;9R'7SF0*<
M$= /FXYZ]:[?90I)\^KZ?UZF'-*;7*>D>5_TTD_.CRO^FDGYU)17";D?E?\
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MS[UT=%(9"+6!;MKH1CSV4(7[X':IJ** "BBB@ HHHH *\K^+FGZJ-1T"_P!
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M$?6K%<OJFE?V5,-4M7D$,<RR/;)]T=F/6MG2M5CU:"26*-D"/MPW7H#_ %H
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%[_QZ/\
MA_.IZ@O?^/1_P_G0 ^#_ (]X_P#<'\JDJ.#_ (]X_P#<'\JDH **9-GR)-JL
MQVG"J<$\= >QK!TR#5H[JSDG^T,C(PFCEDRL(RY&"&.XC*KR#D#.1TH FD_Y
M'FV_[!LO_HV.MNLG[!>-XE;47>#R4MC!"B@[B&96)8].J\8K2_??],_UH DH
MJ/\ ??\ 3/\ 6C]]_P!,_P!: )**C_??],_UH_??],_UH DHJ/\ ??\ 3/\
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M_K0!)14?[[_IG^M'[[_IG^M $E07O_'H_P"'\ZE3?SOV^V*BO?\ CT?\/YT
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MT8?[K_D/\:/[1A_NO^0_QH DO+9[J$1I<RVYSG?%C/TY%4?['N?^@S??FO\
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9&'^Z_P"0_P :BN;Z*2W9 KY..H'K0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Q ?T# 2(  A$! Q$!_\0
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M_OD4>2GJ_P#WV?\ &CR4]7_[[/\ C0 >1#_SR3_OD4>1#_SR3_OD4>2GJ_\
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MY%'DIZO_ -]G_&CR4]7_ .^S_C0 >1#_ ,\D_P"^11Y$/_/)/^^11Y*>K_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\[_IG)_WS1YW_3.3_OF@"2BH_._Z9R?]\T>=_P!,Y/\ OF@"2BH_._Z9R?\
M?-'G?],Y/^^: )**C\[_ *9R?]\T>=_TSD_[YH DHJ/SO^F<G_?-'G?],Y/^
M^: )**C\[_IG)_WS1YW_ $SD_P"^: )**C\[_IG)_P!\T>=_TSD_[YH DHJ/
MSO\ IG)_WS1YW_3.3_OF@"2BH_._Z9R?]\T>=_TSD_[YH DHJ/SO^F<G_?-'
MG?\ 3.3_ +YH DHJ/SO^F<G_ 'S1YW_3.3_OF@"2BH_._P"F<G_?-'G?],Y/
M^^: )**C\[_IG)_WS1YW_3.3_OF@"2BH_._Z9R?]\T>=_P!,Y/\ OF@"2BH_
M._Z9R?\ ?-'G?],Y/^^: )**C\[_ *9R?]\T>=_TSD_[YH DHJK<:A;VL;23
ML8U4 G(]3CI4OG?],Y/^^: )2<#)KC[G49?$&L0V5J6^Q*ZNY P2 <DG/OTK
M6U^ZG6RCAM6DCN)I5C0XQGUKG];O9/ ?@?5+Y,O>$[+=A'G,C85,@^YSBG%.
M320F[*YVT<4,+R>6J*SG>^.I/J?RJIJ?_++\?Z5Y7\$AK%]JWB35M9FN)+C>
MENXN,[E?+.PP?N@;AQ[UZIJ?_++\?Z5=6')+EO<49<RN6X/^/>+_ '!_*I*C
M@_X]XO\ <'\JDK,H" 1@C(-0K:6R",+;Q*(\[ $ VYZX],U-10 V.-(8Q'$B
MHB\!5& /PK%\)?\ (OC_ *^KK_THDK<K#\)?\B^/^OJZ_P#2B2@#<HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHI"RKC) R<#)ZF@!:Y#Q%J-Q<W<^GP@1I; 3-(&(8X&?ZBMCQ'J0T_3&"Y
M\V8&-,'&..3^%>(^,+R[O9HH]*OX9%L;:35'N$.\D1850#Z$MC!K2G!SE8F4
MK*YZ#(MYKD<UVS _9( )&/5L9-=[:3K/80S@G:\8;GZ5\Q#Q7XDUB);C31<I
M9V<$;ZHT*XCR&W$MCH,+QZ\BO>]#UE)]$N8GVJMM -K%OO @\_RJJM&5.UQ1
MFI;%&_\ $4$U_!J5Q,MII5DP:22=@H#\X&>Y/0"O+-#?7OBWX_M=1O8G31K.
M59)(@S^0@3!V#_;;C/XUT_BA-/ND\+^#[B4-)JU_%=7484AA!AL 'MDC'K7I
M?AWPQI7A6SN+32(&A@GG:=D+EL,0!@9[8 XK2$E2A?[3V]"6G*5NB-&WLK6T
M>=K:WBA:>0RRF- ID<@ L<=3P.:KZG_RR_'^E7ZH:G_RR_'^E<IJ6X/^/>+_
M '!_*I*H7LD\6B/);36\,R1AE>X;;&,8^\>PQWK/\.7<UQ+<K-K%KJ#[$D=;
M=U=878ME5*@?)@#&<G@YH WZ*** "L/PE_R+X_Z^KK_THDK<K#\)?\B^/^OJ
MZ_\ 2B2@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBFNZQQL[D*J@DD]A0 ZN,\2:W$FM644;AOLTFXH3C<XY('
MK@5NWVN00:1]OM=MPK,$7G'/O7FEWX?U"^,_BTF>6>.Z6&"W'W%B+ 32X[Y!
M;Z;>]5&-]Q-V*'C&_P!7UFRNK315GN+Z[N3;&)>2%*%F SQ]SOZ5N?#GX=#2
M(O%%GK&G V=Y*+:'S2"TD !R=PY )(].1[4[P7!?3>/6NH[61=)^Q2,96C&T
MW D\HX;UVITKU*MG-PAR+KJ0HJ3YF>=VGPUM?#GASQ?:6%TQAU:!Q#&4Y@4(
MP"Y));ECS6'X>UW3[CPY=7%M<"=%M%CEV@C:PVDCGJ<5[!7SKX>MI]-\-^(9
M);=XT:XN6B5A@LH!7@?4$47=2+<GK=?Y!\+T-[X2>$H]?F/C35VN6NH[QC9(
M6(0+@\X(Y&7.,<<5[96-X1L)=*\':-83KMFM[.*.0>C!1D?G6S45IN<V^@X1
ML@JAJ?\ RR_'^E7ZH:G_ ,LOQ_I618S4HY)O#MQ'%!#.[6Y BG *-QT() Q]
M2/J*R_"<<ZM=//;+'N6/9(;>.&1Q\W58V8%1V/&<GTK9N;2WOM&>VN_^/>2'
M$F3@;<<Y]JIZ79:?9:K<'3[<I'<01OOCD4P@ M@*H/RYR3P,'ZYH V'&48
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MV2_\]O\ QVI** (]DO\ SV_\=HV2_P#/;_QVI** (]DO_/;_ ,=HV2_\]O\
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MC!PH+,>@QGIZ=J .RHHHH *P_"7_ "+X_P"OJZ_]*)*W*P_"7_(OC_KZNO\
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MUWPIXAU0VRBZU&]EO(0B[V*A\*%/7D9Q]:Z'QAHMYJ^BMIMNBI,]RBDRG:J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>OR Y_$^_6LA=>\4>#)I[+0K6.?2T,B6UMA<":4[E..NU6#=_P"*O>*XV_\
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M&M_+4 RJ)'QW)%5S/EL*VMS250H 4  = *6BBI&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5#4_P#EE^/]
M*OU0U/\ Y9?C_2@!;J[2QT<W,APB1KD^F<#/ZUS?@)=JWVQF$0$8"MMR6^;<
MQ(4;B>.3SP.375K_ ,>(Y8?NNJ]>G:N3\ &*1-0F@F#1R&-@GVGSF4X.2W)P
M2<\?ASC) .SHHJB-9TPI$XO[8I-N\MA(,-@X.#]010!>K#\)?\B^/^OJZ_\
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M!'YP_N2?]\&CSA_<D_[X-244 1^</[DG_?!H\X?W)/\ O@U)10!'YP_N2?\
M?!H\X?W)/^^#4E% $?G#^Y)_WP:/.']R3_O@U)10!'YP_N2?]\&CSA_<D_[X
M-244 1^</[DG_?!H\X?W)/\ O@U)10!'YP_N2?\ ?!H\X?W)/^^#4E% $?G#
M^Y)_WP:/.']R3_O@U)10!'YP_N2?]\&CSA_<D_[X-244 1^</[DG_?!H\X?W
M)/\ O@U)10!'YP_N2?\ ?!H\X?W)/^^#4E% $?G#^Y)_WP:/.']R3_O@U)10
M!'YP_N2?]\&CSA_<D_[X-244 1^</[DG_?!H\X?W)/\ O@U)10!'YP_N2?\
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M)_SV/_?(H\N3_GL?^^10!)14027'S3'/LHI?+D_Y['_OD4 245'Y<G_/8_\
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M9)M\,,8D!/E$H6)'!WX&,CWKI** ,OP^]_)I*G4E87(D<'<.J[C@C(!QC'4
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M_P"67X_TJ_5#4_\ EE^/]* ,X=!]**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
2B@ HHHH **** "FMVHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Oct. 28, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,395,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 192.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 28, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 1,395,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">192.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">192.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 1,395,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236412_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236412_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236412_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236412_exfilingfees.htm">dp236412_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236412_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236412_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236412_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236412_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236412_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236412_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236412_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236412_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-013761-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-013761-xbrl.zip
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M4IP8,XC@.MUU!VOQG*2R6HCGE<9G)97+;<PC-9ID3H<A35C(R @0 G8ZYF)
M6 @ I7\0;%8.$#H35%BD M$ @HS<F/PL$]R2BS81&$E4*?+?/AV<*W+S$4>D
M9.10D!%<G2N"C$3&=Z>,_UPF0'_6=LTQXF)LD7.E \"PNU5/H!:U"4=-,D1W
MKHV=X^#&,7@\HQW@[N#,I(/P.9-RB$7C,G)<AR@^>CHJ2P*$R:O)-35-X@37
MP1T ;_9MP&@@!S81,- QR_?]MDTY=UK>A/N1N".=<\7XRHCG,J$@"LJCHT%*
MUS2EDM-S%R=GF1EL:VF $B?!+0D57:F\?TK5&]>-YA6JOW]_OPDY,'WYO0/V
M&M? #@Q;#<<DHX]DO)YN5JFH\.<DJZFJMJF(=Z3KR 32;*\G!.Z6S693>E'-
MZL5EA#)S)I24&>D0!OF/\ A,[HDR-WK$QD /^6&IW&.2M/12OLSCY8^4_)$>
M<5.9/"? A\\53B'5D<!O(U;F20?L<+?/XMSX@; \D=^7V/CJ=N!)V$I?-26$
MBR");ZGI[6B!FG*I0PE#OG!D86RI-3[.VFS^X068.>G:L!Q?F:R9U%> ^8G8
M;:!KP@YT_+K#-_#-1(SJB'*E<B;]3 :VIEL!NK&KL\QK7'/$,DLY"9?F]3+A
MW0,.7'.14 (S<0GE205,FD]I:DH_B<A$:Z^?(XZYY*EP90%S\UR$]R=F3^8,
M^B_J#/K?SI#8&2:1\<<ZPJ^GY+Y# PT_W%^^5JY-,.\S4IF4C64 "M&%2Z_H
M2(S+B'CPQ'(J$_[AYW<1X3T,R68=F0!J,T*9UWDL2+U1-04;F@YD!>:%]9>-
M69<Z*>%Z903%VRF:W&B[0K@V5'2ZO"FKNQ2GWTAX0YHJA2W:A9:.T6XOA!D2
M>5%&;=<RH?09I69*3V\CTH6UE WP=,(6DJY5KVL/U]56XZ:);NIH6H&A5O7B
M6M9A>V1F>3$)#42",C)WHE3N4]GY\FI3&=3O4B@5M,O<OH>N++>-+?0)LQ<B
M./H RV!BCAJ.D=Z4I03NM:E>IU4SU+&4RT9-R#Y[O99+<2E!FGE]IX\1YNBJ
MCR5*E\W+VG89;+- UBN&QR@+S9#I]ML6F151DR)ZV)1J"\ +B86.-+A4I3D/
MTE + U6DE64;9HU1H DH>DV$'1/5,&-C.1(:8F9"7V;T&<@=[5#A/VP0RYHP
M>:ZHBG_-/6R$U['&+Q3,9V>B!L.U+.QQN!W^.D5#:HJ>A%/_);M4P18@\>T_
M($Q0 UNA.@+9$ON%W_F:(?*0J@Y$__U/K:">0A-L+@92T_D$4%H2H+VC*B2"
M2H;K9&N82MM350*8+1IFK[+ME^\YZ\(_;-EV/-GZ=IS$AS!<75C8>$$0$A%W
M+0K0U]!NH(8@-I)CJ 5"A)$SRB$RX"T5>1VY2?0;[YE:S<*<HY:<Q>V<:-,5
M_N!OMU3DV+^&+:-O^2/1LS;+5-!=?P_R56VW[XA8DHOA6( 5\A'D,>A^=24I
MA5OF>BZ'[/D)CZC=MU'8- =2WD)U0- MM'(/4(]OG7I(M-KM,M*5KX5"\@'E
MO9CV#NAN7;*)Y=P."FLUZ3JR6U@;F!;6"5 4S48EBW2$LI3EO^_L_\XKFVYD
MPYB33;ULII2.-11RM8RH #S&XF0UOTUTN4U>E<SQ OG[)0A3<8\*DI(%-9$O
M/X8,>RL:Q5M&!MP:WYIUJSO?R,2&TBAX(R4;&E%NNZY%L-/!EGS-%+4Y>=7?
MT!S81&V(6IB:KQO+5?O\30*$$>O>$./7'6]<A"FCFE*Y)&VQ$7<).8"\FXP'
M/6GGBSX1D_;M5(LP&SS&H2Y#?N(-7GS)-V)O4O-KMU4JA]K1FY]=_M8'4G4N
M7V2;>YA@_1D'RRH50'3(CKY;8'^T%/%<9]CP\\.4Z:HMP)Z@7=BNIH+D.,SG
M>3)D0R8QJ T;P.]8XZP[?=MTQ60YF2ODE(IVG"WE0ZE"=M8XY&_?*R.D_]!W
M9;J',D.Z<$Q8.1N-2=IHUK];UKR45575'R K5#DB+N]N!2U,C+JYL DVV0(!
M(?+*2BHFE#]TWK)41:6BID$B+7NB[=N$("'LRMU:[02L5M+3A25[\:?-T'JR
M#%WZB3.T'F.T *7$C>@1MN\4/<.$-C>V38<C6NA:H+/89U[6=Y"7I2> DIG,
MSYO[UEQN+NAOL=C/F)IG7$ >=_E%T_*,G+D@KO^*67E&SOQ;Y/S)$O*,0(5?
M+R'/R%=<9;!58YS<QF.<^7EWDH%W(IAM3=>WAFA'X_X?CF<OLJ\>/4[?16X!
MQ[;T\G\L\[:F>EI.61'C6J[ UG3X'4R/>7G'\;,EK.B,G(RCBX\1)(^GLW%X
M&D-/WMR*KKNS+36$F617&BCMM*W;R,G\_DOV=-3M0UOG-V%K'&V/=]YJP*A)
MW:49B^I&Q<!NC2BC!2=K@\3.+;7N3=B;X_$;0AGH8Z?VUWZ\_9M$^-:_[).?
MTO+3HV'*PLB\YJ$-S0[:V''H+NJ)0G?&/UHV<VHN^'!('A219TU0E5%L':,/
MQ!H0Z1;'Z!X[/.5_.W0JK>\R$+C;/LRKQYJJ'>OY_-'Z,W%J_/6W]XK^BA-V
MA<5G097*U\1__#,"!U'5(H=/A_QH*V?M$IU:77KJ;NW.^ZO/!>V,EW5>^84G
M@:>OIQ94N*"YS(H<%A%<.R*46E00X0:6G_EHB<;&Q2PDAAY!G>!,<@?B@P=I
M'10D>DCT* ]7O#[C?>P(.8"58S<4O,X"YX=-"9 D]DH850W_ (-6RF;]\Z'
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<97,N:'1M4$L%!@     !  $ 1P   (8+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp236412_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-28</startDate>
            <endDate>2025-10-28</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-28</startDate>
            <endDate>2025-10-28</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-10-28</startDate>
            <endDate>2025-10-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">1395</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">1395000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">192.65</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">1395000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">192.65</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">192.65</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">1395000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
